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 The population of individuals with multiple chronic conditions is growing and is 
estimated to have the highest healthcare utilization among other subgroups. Diabetes and major 
depressive disorder are two of the most common co-occurring chronic conditions. Those with co-
occurring diabetes and major depressive disorder tend to incur higher healthcare utilization but 
lower rates of guideline-concordant care, compared to individuals with either condition only. 
While prior research has associated mental health specialist care with higher level of guideline-
concordant depression care in individuals with depression, the increasingly shifting of treatment 
modality towards pharmacotherapy has led to more depression care at primary care settings.  It is 
critical, therefore, to determine the effect of mental health specialist care on healthcare 
utilization, particularly among adults with co-occurring diabetes who are very primary care-
based.  
 Using an economics theoretical framework, the objective of this study is to examine 
whether mental health specialist use affects healthcare utilization of adult Medicaid beneficiaries 
with co-occurring diabetes and major depressive disorder. First, with mental health specialist 
supply as instrumental variables and person-level fixed effect specification, this study examined 
primary care visit as well as guideline-concordant care for both major depressive disorder and 
diabetes as outcomes of interest. Second, this study investigated emergency department and 
hospitalization utilization outcomes with instrumental variables and General Estimating 
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Equations method. Results from this study show that mental health specialist care increases 
likelihood of receiving guideline-concordant depression care, reduces number of all-cause 
emergency department visits, and reduces likelihood of all-cause hospitalizations. It also 
increases probabilities of visiting a primary care provider and receiving annual eye exam, but 
decreases adherence level of receiving annual lipid test and A1c tests. Findings suggest that 
individuals with co-occurring diabetes and major depressive disorder will benefits from mental 
health specialist care as quality of depression care improves and emergency department and 
hospitalization utilization reduce. However, any policy aiming to improve mental health care 
delivery also needs to address the spillover effect of mental health care on other co-occurring 
conditions. Several areas for future research are suggested to advance our understanding of 
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CHAPTER 1. OVERVIEW 
1.1 Specific Aims  
   The population of individuals with multiple chronic conditions (MCC) is growing with 
the highest healthcare utilization in the US (G. Anderson, 2010; Goodman, Parekh, & Koh, 
2012). Diabetes and major depressive disorders (MDD) are two of most common chronic 
conditions that tend to co-occur (Centers for Disease Control and Prevention, 2012; Egede & 
Ellis, 2010). Healthcare outcomes for these individuals tends to be worse, including lower 
adherence to guideline-concordant care and higher emergency room and inpatient utilization, 
compared to patients with either diabetes or MDD only (Desai, 2002; Egede, 2004). While 
depression is also a barrier to receiving guideline-concordant diabetes care, only a minority of 
patients with diabetes and MDD receive guideline-concordant care for depression (Egede & 
Ellis, 2010; W. J. Katon et al., 2004). The two major types of providers for depression care are 
primary care physicians and mental health specialists, including psychiatrists and other non-
prescribers (Olfson et al., 2002; Wang et al., 2005b). Some research has demonstrated that 
mental health specialist care leads to 10%-20% higher levels of guideline-concordant depression 
care than primary care in individuals with MDD (W Katon, von Korff, Lin, Bush, & Ormel, 
1992; Sturm, Meredith, & Wells, 1996). Yet mental health specialists and primary care were not 
directly compared in individuals with diabetes and co-morbid MDD. Thus evidence of mental 
health specialist care on guideline-concordant care in this population is less clear. 
 The utilization of mental health specialist care for depression remains low (Pratt & 
Brody, 2014b; Wang et al., 2005b; A. S. Young, Klap, Sherbourne, & Wells, 2001). In fact, 
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primary care physicians have become more engaged in providing depression care with 
pharmacotherapy (Lambert, Agger, & Hartley, 1999; Ng, Bardwell, & Camacho, 2002; Wang et 
al., 2005a). This is in part due to the introduction of newer antidepressants and the supply 
shortage of mental health specialist (Lambert et al., 1999). In reality, mental health specialists are 
not equally accessible to all patients. Thomas and colleagues reported that three-quarters of U.S. 
counties have a severe shortage of psychiatrists as well as other mental health specialists 
(Thomas, Ellis, Konrad, Holzer, & Morrissey, 2009). Lower supply of mental health specialist 
was associated with lower utilization of mental health specialist care among patients with MDD 
(Ettner & Hermann, 1997; Lindrooth, Lo Sasso, & Lurie, 2006). In light of the shortage of 
mental health specialist and the shifting of treatment modality towards pharmacotherapy, many 
studies have suggested that MDD is a chronic illness that can be effectively treated in primary 
care settings (Ford et al., 2002). As individuals with diabetes and MDD are mainly managed at 
primary care, examining the role of mental health specialist among this population is critical.  
 My long-term goal is to expand the understanding of the effect of different types of 
outpatient providers in the healthcare utilization of patients with co-occurring diabetes and 
depression. The objective of this dissertation is to examine how outpatient mental health 
specialist visits are affected by mental health specialist supply and whether mental health 
specialist use affects other types of healthcare utilization in this population. The central 
hypothesis is that mental health specialist use improves guideline-concordant care and reduces 
emergency room and inpatient services utilization. To test this hypothesis, this study proposes to 
conduct econometric analyses with Medicaid Claims data in North Carolina to test the following 
specific aims: 
 Among Adult Medicaid beneficiaries with co-occurring diabetes and depression, 
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 Aim 1: To estimate the effect of mental health specialist supply on mental health 
specialist use and primary care visits.  The main hypothesis for this aim is that lower mental 
health specialist supply will decrease mental health specialist use, but mental health specialist 
visit could either increase or decrease primary care provider use depending whether primary care 
physicians and mental health specialists are substitution or complementary goods. By analyzing 
changes in local supply of mental health specialists, this Aim examined changes in probability of 
mental health specialist and primary care provider use using maximum likelihood estimation.   
 Aim 2: To estimate the causal effect of mental health specialist use on guideline-
concordant care. The main hypothesis for this aim is that mental health specialist care will 
improve guideline-concordant care for both depression and diabetes. It compared guideline-
concordant care utilization between patients who had mental health specialist care and those who 
did not. The utilization outcomes are measured for depression care and diabetes care separately. 
An instrumental variable approach was implemented to correct the potential endogeneity of 
mental health specialist use. 
Aim 3: To estimate the causal effect of mental health specialist use on emergency 
department and inpatient service use. The main hypothesis for this aim is that increase in 
mental health specialist use reduces tertiary care. It compared tertiary care utilization between 
patients who had mental health specialist care and those who did not. An instrument variable 







1.2 Background  
1.2.1. Individuals with multiple chronic conditions 
Individuals with multiple chronic conditions (MCC) are a growing population in the 
United States. Roughly 1 in 4 Americans lives with the burden of more than one ongoing chronic 
condition, accounting for an estimated two-thirds of total US health care spending (G. Anderson, 
2010; Machlin & Soni, 2013; Ward & Schiller, 2013). Individuals with MCC face complicated 
clinical needs and increased healthcare demands associated with adherence to complicated 
treatment regimens (E. a. Bayliss, Ellis, & Steiner, 2007). Healthcare utilization of individuals 
with MCC is usually much higher than their counterparts. For instance, the average expense 
among people with 4 or more chronic conditions was approximately 7 times greater than for 
people treated for no chronic conditions or only 1 chronic condition (Machlin & Soni, 2013), and 
nearly all of Medicare spending (96%) is on behalf of people with MCC (Weiss, 2007; Wolff et 
al., 2002). Today the number of persons living with MCC is still increasing dramatically in the 
United States (Bayliss et al., 2014). As this population grows, they and their healthcare needs 
have become challenging to both the clinical communities and policy authorities. 
1.2.2. Diabetes and major depressive disorder 
Diabetes and major depressive disorder (MDD) are two of the most common chronic 
diseases in the United States, and continue to increase in numbers and significance. Prevalence 
of diabetes has steadily increased since 1990 (Centers for Disease Control and Prevention, 2012). 
As of 2012, diabetes occurs in approximately 11.7 % of persons aged 45-64 and 18.9% of age 
65+ in the US (Centers for Disease Control and Prevention, 2012). If the current growth trend 
continues, at least one of three adults in the US will be diagnosed with diabetes by 2050 (Boyle, 
Thompson, Gregg, Barker, & Williamson, 2010). As a major cause of heart disease and stroke, 
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diabetes can lead to severe health complication and even death when not managed appropriately 
(Centers for Disease Control and Prevention, 2012). MDD is also a common chronic condition in 
the US. It is a serious medical illness with mood, cognitive, and physical symptoms (American 
Psychiatric Association, 2013), associated with impaired functioning, diminished or lost 
productivity, increased health care utilization, decreased quality of life, and higher rates of other 
chronic disease (Egede & Ellis, 2010). Currently, MDD affects approximately 18.8 million 
adults, or about 9.5% of the U.S. population aged 18 years and older in a given year (Egede, 
2007). Major depressive disorder is more prevalent among women than men, and approximately 
25% of women and 16% of men will have a major depressive episode during their lifetime 
(Ronald C Kessler, Petukhova, Sampson, Zaslavsky, & Wittchen, 2012; Pratt & Brody, 2014b). 
It is well established that psychiatric disorders tend to co-occur with chronic general 
medical illness. While both diabetes and MDD have significant public health implications, 
diabetes and MDD is actually one of the most prevalent combinations (Sambamoorthi, Olfson, 
Wei, & Crystal, 2006). They are considered one of the “natural clusters” of chronic illnesses—
illnesses that tend to co-occur, mal-adaptively affect each other’s course, and for which there are 
often overlapping guideline recommendations (Wayne Katon, Unützer, Wells, & Jones, 2010). 
Adults with diabetes have an increased risk of experiencing one or more depressive episodes in 
their lifetime than the general population, and the prevalence of MDD in patients with diabetes is 
estimated to be between 11% and 20% (Ali, Stone, Peters, Davies, & Khunti, 2006; Wayne 
Katon, Maj, & Sartorius, 2011). In one study, the prevalence of MDD among individuals with 
type II diabetes was even up to 39% (Sambamoorthi et al., 2006; Téllez-Zenteno & Cardiel, 
2002). A meta-analysis concludes that comorbid MDD is more prevalent in individuals with 
diabetes than in other primary care patients (R. J. Anderson, Freedland, Clouse, & Lustman, 
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2001). Major depressive disorders are also shown to be associated with increased risk of obesity 
and developing diabetes (Eaton, Armenian, Gallo, Pratt, & Ford, 1996; Knol et al., 2006; Pratt & 
Brody, 2014a). 
1.2.3. Worse health outcome associated with diabetes and major depressive disorder 
 Substantial evidence has suggested that MDD is associated with adverse health outcomes 
in diabetes such as higher HbAlc levels and an increased likelihood of complications among 
patients with diabetes. For example, an earlier meta-analysis concluded that MDD was 
significantly associated with poor glycemic control in individuals with diabetes with a 
standardized effect size of 0.17 increase on glycohemoglobin (Lustman et al., 2000). Higher 
HbA1c and more diabetes complications were found in African Americans with higher 
depressive symptoms (measured by Epidemiological Studies Depression scale (CESD)) after 
controlling for confounders (mean difference: 0.20 on HbA1c, 0.47 on number of complications) 
(Wagner, Abbott, Heapy, & Yong, 2009). Another meta-analysis found significantly greater 
diabetes complications including diabetic retinopathy, nephropathy, neuropathy, microvascular 
complications, and sexual dysfunction among patients with co-morbid MDD (De Groot, 
Anderson, Freedland, Clouse, & Lustman, 2001). A potential pathway from co-morbid MDD to 
worse diabetic outcome is worse adherence to diabetes care. Depressive symptom severity is 
associated with less adherence to dietary recommendations (adherence z-score -0.18 vs 0.28) and 
approximately twice as many interruptions in refills of oral hypoglycemics (Ciechanowski, 
Katon, & Russo, 2000). A systematic review of treatment adherence among individuals with 
diabetes and MDD also indicated that there was a significant relationship between MDD and 
treatment non-adherence (mean difference in HbA1c: 0.13) (Richardson, Egede, Mueller, Echols, 
& Gebregziabher, 2008). 
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 Therefore, just like most MCC combinations, the impact of those two chronic conditions 
on health outcomes is greater than what it would be for patients with single conditions. 
Individuals with diabetes and comorbid MDD have higher odds of functional disability 
compared with individuals with either diabetes or MDD alone (Egede, 2004). Another large 
study also found that the coexistence of diabetes and MDD is associated with significantly higher 
mortality, and this risk is beyond that due to having either diabetes or MDD alone (Egede, 
Nietert, & Zheng, 2005). Further, while diabetes and MDD were independently associated with a 
greater risk for dementia, the combined association of both exposures with the risk for all-cause 
dementia was stronger than the additive association (Wayne Katon et al., 2015). 
1.2.4. Mental health specialists and primary care providers for depression care 
 The major providers for depression care in the US are primary care physicians and mental 
health specialists, including prescribers and non-prescribers (Olfson et al., 2002; Wang et al., 
2005a; A. S. Young et al., 2001). The core mental health specialist group as six major 
professions: psychiatrists, psychologists, advanced practice psychiatric nurses, social workers, 
licensed professional counselors, and marriage and family therapists. These six groups constitute 
a majority of mental health professionals, and information about them is critically important for 
mental health policy and planning, such as designation of shortage in the mental health 
profession (Health Resources and Services Administration, n.d.). Their roles in providing mental 
health services could be distinct as well as overlapping.  For instance, psychiatrists prescribe 
medicine and conduct psychotherapy, while other non-prescriber specialists only provide 
psychotherapy. Psychologists provide testing and group therapy in institutional settings, while 
social workers and other therapists also provide family counseling, psychosocial assessments, 
and discharge planning (Stefos, Burgess, Cohen, Lehner, & Moran, 2012).  
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 The introduction of selective serotonin reuptake inhibitors (SSRI) shifted treatment 
modality towards more pharmacotherapy during the 1990s (Olfson et al., 2002). Many SSRIs 
need only once-a-day dosing, require less frequent dose iterations, and are associated with fewer 
adverse events (Simon et al., 1996). Beginning in 1999, the SSRIs and other new antidepressants 
like bupropion began coming off patent and the availability of generics further continued the 
trend of greater medication use. For example, between 1996 to 2005, the percentage of adults 
with depression who received antidepressants increased from 65.1% to 75.2%, and the 
percentage who received psychotherapy for depression decreased from 56.6% % to 37.5 % 
among Florida Medicaid beneficiaries (Fullerton, Busch, Normand, McGuire, & Epstein, 2011). 
Rural individuals are even more reliant on pharmacotherapy than psychotherapy compared to 
those in urban areas (J. C. Fortney, Harman, Xu, & Dong, 2010).  
 Back to 1990s, a much higher proportion of individuals with major depression used 
depression care at mental health specialty sectors than at general medical sectors (21.2% vs 
12.1%), according to the National Comorbidity Survey conducted in 1992 (R C Kessler et al., 
1999). As the modality shifted to more pharmacotherapy, primary care physicians have become 
more engaged in providing depression care with pharmacotherapy, especially in rural areas 
where there is a limited supply of mental health specialist (Lambert et al., 1999; Ng et al., 2002). 
In fact, the National Comorbidity Survey replication in 2003 showed that 32.5% of individuals 
with major depression utilized services in the general medical sector, while only 20.6% used 
psychiatrist services and 23.1% used services provided by other mental health specialists (Wang 
et al., 2005a). The growth of depression care utilization in primary care is higher than that in 
mental health specialty sectors (Wang et al., 2005a), as both the growth rate and use rate of 
mental health specialist remained low (Wang et al., 2005a; A. S. Young et al., 2001). Low rates 
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of mental health specialist among individuals with depression are also documented in other 
studies. For example, a prior telephone survey found that during 1997 and 1998, while 77.7% of 
individuals with a depressive disorder have seen a primary care physician, only 17.7% had seen a 
mental health specialist (A. S. Young et al., 2001).  A more current National Health and 
Nutrition Examination Survey found that during 2009-2012, only 35% of all Americans with 
severe depressive symptoms reported having seen a mental health professional within the year 
(Pratt & Brody, 2014b). 
1.2.5. Mental health specialist supply 
The lack of access to mental health specialists has been a critical factor contributing to 
the low growth and low rate of mental health specialist use. An earlier study indicated that in 
2001, over 50% of U.S. counties have whole county shortages of mental health specialist 
(Merwin, Hinton, Dembling, & Stern, 2003).  In 2007, Thomas and colleagues reported that 
about three-quarters of U.S. counties were estimated to have a severe shortage of psychiatrists as 
well as other mental health specialists (Thomas et al., 2009). Literature indicated that provider 
supply is an important determinant of outpatient service utilization in general populations, and its 
effect is particularly evident in the mental health sector. For example, Ettner and colleagues 
(1997) found a greater number of psychiatrist per 1,000 county residents is associated with a 
higher probability of mental health specialist use in Medicare beneficiaries with depression as 
well as other mental health conditions (Relative Risk 1.34 for aged and 1.12 for disabled) (Ettner 
& Hermann, 1997). Although Ettner and colleagues (1997) found that a greater number of 
psychologists is associated with lower probability of mental health specialist use among disabled 
Medicare beneficiaries, they argued that this is because many beneficiaries pay out-of-pocket for 
psychologist services (Ettner & Hermann, 1997).  Lambert and colleagues (1999) also found that 
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higher number of core mental health providers in a Primary Care Analysis Area (PCAA) is 
associated with both higher odds (OR: 1.12) and higher number (0.133) of mental health 
specialist visits among Medicaid beneficiaries with depression in Maine (Lambert et al., 1999). 
A lower mental health specialist supply might reduce utilization through longer distance to care 
or more travel time, as mental health care utilization is very sensitive to distance to providers 
(Lindrooth et al., 2006; Schmitt, Phibbs, & Piette, 2003). Increased travel time to providers was 
found to be associated with fewer visits and a lower probability of receiving care consistent with 
guidelines for the treatment of depression (J. Fortney, Rost, Zhang, & Warren, 1999). Although 
the extent to which primary care providers can act as substitutes for mental health specialists has 
been unclear (Eisenberg, 1992; Mechanic, 1990), a low supply of mental health specialist might 
also contribute to the rising rate of primary care physicians treating mental health problems, 
along with the treatment modality shifting. Lower number of psychiatrists per county was found 
associated with increased use in the primary care sector among Medicare beneficiaries with 
mental health conditions (Relative Risk 1.34 for aged and 1.12 for disabled) (Ettner & Hermann, 
1997). 
1.2.6. Mental health specialist care for individuals with co-occurring diabetes and major 
depressive disorder 
For individuals with MCC, mental health services are often provided by primary care 
physicians in conjunction with care of non-psychiatric conditions (Robiner, 2006). Primary care 
physicians are often the initial health care contact for patients with depression (Norquist & 
Regier, 1996; Williams et al., 1999; A. S. Young et al., 2001). Given patients’ frequent contact 
with primary care providers, the impact of mental health specialist care in this population is 
unclear. As mental health specialists are not accessible to all, it is important to investigate the 
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implications of mental health specialist care among those with co-occurring mental health and 
physical health conditions. This study is focused on individuals with co-occurring diabetes and 
depression, as those two are the most prevalent chronic conditions.  The previous literature 
presented the effect of mental health specialist on guideline-concordant depression care among 
those with depression, but provided limited evidence on the population with co-morbid diabetes. 
Further, prior studies that investigated the effect of mental health specialist care on guideline-
concordant diabetes care had notable study limitations, and the evidence is still inconclusive. 
Finally, very little evidence is available on the effect of mental health specialist care on 
ER/hospitalization use in individuals with depression and diabetes. In the era of promoting 
integrating mental health into primary care settings, it is critical to re-examine the role of mental 
health specialists in caring for depression as well as the effect of mental health specialist care on 
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CHAPTER 2. STUDY 1: WHO SHOULD TREAT DEPRESSION AMONG ADULTS 
WITH CO-OCCURRING DIABETES? – THE EFFECT OF MENTAL HEALTH 
SPECIALIST USE ON GUIDELINE-CONCORDANT DIABETES CARE OF ADULTS 
WITH CO-OCCURRING DIABETES AND MAJOR DEPRESSIVE DISORDER 
 
2.1 Background  
 Individuals with multiple chronic conditions are a growing population in the United 
States. From 2001 through 2010, the prevalence of multiple chronic conditions has significantly 
increased from 21.8% to 26.9% (Ward & Schiller, 2013). While both diabetes and major 
depressive disorder (MDD) have significant public health implications, diabetes and MDD are 
one of the most prevalent combinations of common chronic conditions that tend to co-occur and 
affect each other’s course (Ali, Stone, Peters, Davies, & Khunti, 2006; Eaton, Armenian, Gallo, 
Pratt, & Ford, 1996; Katon, Maj, & Sartorius, 2011; Pratt & Brody, 2014a; Sambamoorthi, 
Olfson, Wei, & Crystal, 2006). Adults with diabetes have an increased risk of experiencing one 
or more depressive episodes in their lifetime than the general population, and the prevalence of 
MDD in patients with diabetes is estimated to be between 11% and 20% (Ali et al., 2006; Wayne 
Katon et al., 2011). Further, MDD is shown to be associated with increased risk of obesity, 
glycemic level, diabetic complications including diabetic retinopathy, nephropathy, neuropathy, 
microvascular complications, and higher mortality among individuals with diabetes (De Groot et 
al., 2001; Eaton et al., 1996; Egede et al., 2005; Knol et al., 2006; Lustman et al., 2000; Pratt & 
Brody, 2014a).  
 A potential pathway from co-morbid MDD to worse diabetic outcome is worse adherence 
to diabetes care. A systematic review of treatment adherence among individuals with diabetes 
and MDD indicated that there was a significant relationship between MDD and treatment non-
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adherence (mean difference in HbA1c: 0.13) (Richardson et al., 2008). It is well documented that 
adherence to recommended preventive screenings for diabetes was associated with significantly 
reduced rates of hospitalization and better health outcomes (Harman et al., 2010; Sloan, Bethel, 
Lee, Brown, & Feinglos, 2004; UK Prospective Diabetes Study (UKPDS) Group, 1998; Vijan, 
Hofer, & Hayward, 2000), yet rates of screening are still suboptimal. Roughly, 50% of patients 
with diabetes in the US did not receive appropriate diabetes preventive care (Banta, Morrato, Lee, 
& Haviland, 2009; Beckles et al., 1998; Peters, Legorreta, Ossorio, & Davidson, 1996; Sloan et 
al., 2004). It is concerning that individuals with co-occurring diabetes and MDD are less likely to 
receive guideline-concordant diabetes care compared with those with diabetes only (Desai, 2002; 
Domino et al., 2014; Druss et al., 2012; Egede, Ellis, & Grubaugh, 2009; Lin et al., 2004). For 
example, individuals with MDD had lower odds of receiving an annual eye exam than those 
without (OR=0.70) (Egede et al., 2009). A survey conducted in a large health maintenance 
organization also found that those with MDD are less likely to receive HbA1c test within the last 
year than those without depression (6.3% vs 4.0%) (Lin et al., 2004). 
Guidelines recommended that individuals diagnosed with MDD be treated with 
antidepressant medication, psychotherapy, or a combination of the two modalities (American 
Psychiatric Association, 2010). An important group of providers for depression care are mental 
health specialists, including prescribers, such as psychiatrists and psychiatric nurses, and other 
non-prescribers, such as psychologists, social workers, family and marriage therapists, and 
counselors. However, over half of U.S. counties have shortages of mental health specialists 
(Merwin, Hinton, Dembling, & Stern, 2003), and about three-quarters of U.S. counties were 
estimated to have a severe shortage of psychiatrists (Thomas, Ellis, Konrad, Holzer, & Morrissey, 
2009). On the other hand, the treatment modality of depression care has been shifted towards 
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more pharmacotherapy since the 1990s (Olfson et al., 2002). This treatment modality change 
coupled with the lack of access to mental health specialists has contributed to the shifting of 
depression care utilization from mental health specialty to primary care settings (Ettner, 
Hermann, & Tang, 1999; Wang et al., 2005). Research using the National Health and Nutrition 
Examination Survey found that during 2005-2006, only 39% of all Americans with severe 
depressive symptoms reported having seen a mental health professional within a year, and this 
statistic dropped to 35% during 2009-2012 (Pratt & Brody, 2008, 2014b). Primary care 
physicians have become more engaged in providing depression care with pharmacotherapy, 
especially in rural areas where there is a limited supply of mental health specialists (Lambert, 
Agger, & Hartley, 1999; Ng, Bardwell, & Camacho, 2002).   
Some literature has indicated mental health specialist care improves depression 
symptoms more significantly than other providers among those with MDD only (Katz, Kessler, 
Lin, & Wells, 1998; Sturm, Meredith, & Wells, 1996; A. S. Young, Klap, Sherbourne, & Wells, 
2001); in theory, as MDD is associated with lower adherence to diabetes care, improvement in 
depression symptoms could lead to better adherence to diabetes care (Gonzalez et al., 2008).  On 
the other hand, mental health specialist care may also impose additional costs through the 
addition of another specialist and further crowd out guideline-concordant diabetes care. The 
effect of mental health specialist care on guideline-concordant diabetes care among individuals 
with co-occurring diabetes and MDD, however, is less investigated.   
The objective of this study is to examine whether the use of mental health specialists for 
depression care affects guideline-concordant care for diabetes. Because the use of mental health 
specialists is potentially endogenous, I controlled for person-level fixed effects to address the 
endogeneity of mental health specialist use caused by unobserved time invariant person-level 
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characteristics that could jointly determine mental health specialist use and the probability of 
receiving guideline-concordant diabetes care. I also use instrumental variables that identify three 
different constructs of mental health specialist supply. Those instruments together are credibly 
excluded from the main equation predicting guideline-concordant diabetes care. To the best of 
my knowledge, this study is the first to model mental health specialist use as endogenous with 
instrument/fixed effect specifications to determine the “spillover” effect of mental health 
specialist care on receiving guideline-concordant care. 
 
2.2 The Effect of Mental Health Specialist Care 
  Overall, the roles of different types of mental health specialists in providing mental 
health services could be distinct as well as overlapping.  For instance, only psychiatrists and 
psychiatric nurses can prescribe medicine, but most specialists can provide some types of 
psychotherapy, including testing and group therapy in institutional settings, family counseling, 
and psychosocial assessments (Stefos, Burgess, Cohen, Lehner, & Moran, 2012). On the other 
hand, primary care providers can prescribe medicine, but most of them are not trained to provide 
any psychotherapy. 
2.2.1 Effect of mental health specialist care on depression care outcomes 
Many studies have demonstrated the positive effect of mental health specialist care on 
improving guideline-concordant depression care. In the quasi-experimental Medical Outcomes 
Study, patients with MDD seen by psychiatrists had better guideline-concordant depression care, 
measured by antidepressant use and counseling, than those treated by primary care physicians 
only (Sturm & Wells, 1995). In an analysis of the National Comorbidity Survey, 29% of 
individuals with MDD seen by mental health specialists received appropriate management 
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(medication and four or more mental health visits), while only 13.8% of those seen by general 
physicians received same appropriate care, and this difference is higher for persons with greater 
severity of illness (Katz et al., 1998).  However, this study examined the cross-sectional 
correlations without differentiating effect of mental health specialist care from effect of different 
baseline factors between those seeing specialists and general physicians. A quasi-experimental 
study also reported similar findings. This study with a telephone survey among individuals with 
MDD and anxiety disorders examined appropriate care, defined as use of either appropriate 
psychotropic medication or appropriate counseling during the prior year. Their results showed a 
much higher proportion of receiving appropriate care in those with some mental health specialist 
visits than in those with primary care visits only (88.6%-89.9% vs 19.5%) (A. S. Young et al., 
2001). Those results did not directly apply to estimate the effect on care for MDD as separate 
from anxiety disorders (A. S. Young et al., 2001). 
2.2.2 Effect of mental health specialist care on diabetes care 
Very few studies focused on the effect of mental health specialist care on guideline-
concordant diabetes care outcome among individuals with MDD or other psychiatric co-
morbidities. A study utilizing Medicaid claims data investigated the effect of a seeing a fee-for-
service psychiatrist on receiving guideline-concordant diabetes care among California Medicaid 
enrollees with diabetes and psychiatric co-morbidities. Results showed that those seen by a fee-
for-service psychiatrist had higher odds of having lipid testing (OR 2.35) or eye examinations 
(OR 2.03), but had no significant difference on the odds of receiving annual A1c test (Banta et 
al., 2009).  However, it is unclear whether the same effect applies to the subsample with MDD 
and diabetes, as this study was not depression focused.  
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Many collaborative care models incorporate mental health specialty care into primary 
care for individuals with co-occurring diabetes and depression. In a large randomized clinical 
trial (RCT), an intervention delivered by a depression clinical specialist nurse in collaboration 
with the primary care physician showed significant greater improvement in the adequacy of the 
dosage of antidepressant medication treatment, but showed no improvement in HbA1c (W. J. 
Katon et al., 2004). In another RCT for low-income Hispanic subjects, the intervention provided 
psychotherapy by a social worker and antidepressant prescribed by primary care physicians with 
a psychiatrist providing supervision and consultation, while the control arm provided 
antidepressants from primary care physicians only; their results showed improvements in 
functioning and decreased diabetes and pain symptom burden (Ell et al., 2010). To the best of 
my knowledge, there have been no studies examining the effect of mental health specialists on 
guideline-concordant diabetes care for individuals with co-occurring MDD and diabetes. 
 
2.3 Method 
2.3.1 Conceptual framework 
 I consider two types of providers for depression care: mental health specialists and 
primary care providers. I posit that depression care provided by mental health specialists would 
affect receipt of guideline-concordant diabetes care differently than depression care provided by 
primary care providers. There are two potential causal pathways for this differential treatment 
effect.  
 First, mental health specialist care increases the probability of receiving of diabetes care 
by increasing the marginal returns on health to depression care. Major depressive disorder has 
been found to be associated with lower adherence to preventive care for diabetes (Desai, 2002; 
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Domino et al., 2014; Druss et al., 2012; Egede et al., 2009; Lin et al., 2004). Specifically, 
individuals with more severe depression symptoms are more likely to avoid activities that will 
bring rewards in the future, such as healthier diets or exercise (Wenze, Gunthert, & German, 
2012). As a decision maker, while accounting for future consequences of present health 
investment in diabetes care, an individual with depression may misperceive probabilities of 
benefits and harms on future health production from their current health investments. As mental 
health specialists may provide better depression care than primary care providers and more 
effectively alleviate depression symptoms (Katz et al., 1998; Sturm & Wells, 1995; A. S. Young 
et al., 2001), individuals receiving mental health specialist care may perceive higher marginal 
benefits of current investments in diabetes care on health. Therefore, the marginal return of 
mental health specialist care on health production could be higher than that of primary care, and 
thus leads to better adherent to guideline-concordant diabetes care. 
 Second, mental health specialist care could also crowd out diabetes care investment and 
lead to lower adherence to diabetes care guidelines. Individuals who see a mental health 
specialist may be more likely to shift resources from diabetes care to depression care. For 
instance, due to the limited supply of mental health specialists in many areas, travel cost for 
visiting a mental health specialist is usually higher than visiting a primary care provider. In 
theory, within the same budget constraint, the cost and time available for diabetes care will 
become lower among individuals receiving mental health specialist care than among those 
without. Therefore, those individuals are less likely to receive guideline-concordant diabetes care.  
 Another deciding factor for receiving guideline-concordant diabetes care could be the 
dynamic and focus of a primary care visit, as it could be different once an individual receives 
mental health specialist care and the direction of the effect is ambiguous. The “competing 
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demands” model suggests that during a primary care visit for individuals with multiple chronic 
conditions, patients and physicians bring an implicit agenda of issues; however they can only 
address some of the problems due to time constraints, leaving some other problems for 
subsequent visits (Nutting, Rost, Smith, Werner, & Elliot, 2000; Rost et al., 2000). If receiving 
mental health specialist care brings more focus on MDD care during primary care visits, diabetes 
care might be left out or postponed to subsequent visits. As the marginal benefits of subsequent 
primary care visits are reduced, patients are less likely to make those visits; as a result, diabetes 
care is substituted with depression care.  
 Alternatively, the focus of primary care might actually increase the focus on diabetes care. 
As mental health specialists have shared some part of depression care, the primary care visits 
may be increasingly diabetes-focused. Therefore, a subsequent primary care visit on health could 
increase as the quality of diabetes care increases, and this increase in marginal return could 
further increase investment in diabetes care.  
 In sum, although mental health specialist care might increase receiving of guideline-
concordant diabetes care through better depression care, the higher marginal cost of mental 
health specialist care might impose an opposite effect on diabetes care. Further, the focus of 
primary care visits could either increase or decrease the probability of adherence to diabetes 
guideline through affecting the marginal return of diabetes care, depending whether those visits 
are more depression or diabetes-focused.   Therefore, the effect of mental health specialist visits 






2.3.2.1 Estimation Sample 
Data come from the North Carolina Medicaid Analytic Extracts (MAX) from 2006-2011, 
which contains enrollment information and final action claims for all Medicaid fee-for-service 
beneficiaries in North Carolina. The available types of claims include outpatient care, 
prescriptions, emergency room visits, and hospitalization. I restricted the estimation sample to 
adult beneficiaries aged 18 or older who had at least one inpatient or at least two outpatient 
diagnoses of diabetes (International Classification of Disease version 9 [ICD-9] code: 250.XX 
357.2X, 362.0X, 366.41) and MDD ([ICD-9] code: 296.2X, 296.3X, 300.4X, 311.XX) during 
the study period. Data were collapsed to annual summaries and a person-year is included if the 
beneficiary had at least one month of Medicaid enrollment in that year. I excluded person-years 
with: (1) Medicaid and Medicare dual coverage (potential for incomplete information on 
healthcare utilization); (2) long-term care facility service use (beneficiaries are less likely to 
receive outpatient visit claims) or (3) one of the five (of 100) counties where mental health 
services were carved-out during this time period (mental health care utilization for such patients 
were incomplete in MAX files). The final estimation sample includes 22,392 unique persons 
with co-occurring diabetes and MDD during 2006-2011, contributing 76,369 person-years to the 
analysis.  Average age was 45, 22% of the sample were male, 41% were African American, 79% 
lives in an urban area, and the average enrollment in a calendar year was 11 months (Table 2.1).   
2.3.2.2 Key measures 
The primary dependent variables include three binary indicators of guideline-concordant 
diabetes care, following Healthcare Effectiveness Data and Information Set recommendations 
(The Healthcare Effectiveness Data and Information Set, n.d.): whether individual had (1) a lipid 
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test at least once during the year, (2) an A1c test at least twice during the year, and (3) an eye 
exam at least once during the year. It is important to note the different settings for these tests: the 
lipid and A1c tests are usually performed at primary care, where as the eye exam is typically 
performed at an eye specialty setting. .  
Our secondary outcome was having a primary care visit, as two of the three quality 
measures are mostly delivered through primary care (Egede et al., 2009; Sloan et al., 2004). 
Primary care use is measured as an indicator of whether a patient has any visits to a primary care 
provider in a year, identified by outpatient visits to providers with primary care-relevant 
specialty codes. On average, nearly three quarters (72.71%) of the annual observations had at 
least one primary care visit per year during 2006-2011. The average rates of preventive 
screenings are 58.04%, 39.59%, and 17.62% for an annual lipid test, two A1c tests a year, and 
annual eye exam (Table 2.1). 
Mental health specialist use is the key independent variable in this study. It is defined as a 
binary indicator of whether an individual had any visits to a psychiatrist, psychologist, 
psychological associate, mental health nurse practitioner, licensed clinical social worker, mental 
health HMO, Assertive Community Treatment Team, or Critical Access Behavioral Health 
Agencies. On average, 31.6% of the annual observations in this study had at least one mental 
health specialist visit during a year.    
2.3.2.3 Instrumental variables 
  Mental health specialist use is subject to potential endogeneity. First, visits and testing 
may reflect severity of illness not recorded in claims data and not accounted for by the other 
independent variables. Second, since treatment choice could be heavily driven by personal 
preferences, decisions to visit a mental health specialist or another provider could be jointly 
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determined by unobservable person-level factors. Therefore, the effect of mental health specialist 
care would not be identified without correcting for endogeneity.   
Three variables were identified as potential instruments to correct the endogeneity: a 
local preference-based variable determined by the utilization pattern of mental health specialist 
use among Medicaid beneficiaries at the county-level (Basu, Heckman, Navarro-Lozano, & 
Urzua, 2007), the total number of licensed mental health specialists in each county from North 
Carolina Health Professions Data System (HPDS) (Richman, Fraher, & Gaul, 2015), and the 
total number of mental health specialists accepting Medicaid patients. As valid instruments, all 
variables should be independent of diabetes care and only affect diabetes care outcomes through 
mental health specialist use.  In theory, the regional supply of mental health specialists affects 
individual mental health specialist use through affecting travel cost to a Medicaid mental health 
specialist or simply through changing local preferences for mental health specialty care.  
The first instrument, mental health specialist use rate, is defined as the proportion of all 
Medicaid beneficiaries who had any mental health specialist use during the year at the county-
level. This variable represents local preference and geographic variation in mental health 
specialist care selection. The variation in local treatment selection is possibly through a historical 
practice style, which is plausibly independent of underlying health, preferences and outcomes of 
the patients (Basu et al., 2007). The full Medicaid sample regardless of diagnosis was used to 
generate variables reflecting total number of Medicaid beneficiaries enrolled by county as well 
as the proportion of beneficiaries with at least one mental health specialist visit at county-level.  
The second measure, defined as the total number of psychiatrists and psychologists in a 
county, comes from North Carolina Health Professions Data System (HPDS) (Richman et al., 
2015). Due to data availability in HPDS, this measure includes only psychiatrists and 
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psychologists, the two major types of mental health specialist (Richman et al., 2015).  
Nevertheless, this measure is likely to reflect the availability of mental health specialist services 
more generally, as indicated by the high correlation between number of psychiatrists, 
psychologists, and other non-prescriber specialists at the county level (Ellis, Konrad, Thomas, & 
Morrissey, 2009).  
The third measure, Medicaid mental health specialist supply, is defined as the number of 
mental health specialists that had seen at least one Medicaid beneficiaries in a year at county-
level. A Medicaid provider is identified with a unique provider identifier that had at least one 
claim for a Medicaid beneficiary in a year.  The unique identifiers used are state-assigned 
Medicaid billing identifiers prior to 2009 and National Provider Identifier (NPI) beginning 2009. 
The Medicaid mental health specialist supply is measured as the total number of Medicaid 
mental health specialist in a year at county-level. Note that a provider could be counted more 
than once as she might be identified from different counties in a year. The full sample regardless 
of diagnosis was used to identify Medicaid mental health specialist.  The correlation coefficient 
between those two supply measures is 0.6398. 
2.3.2.4 Other control variables 
  Other important control variables included patient demographics, diabetes 
complications, other psychiatric co-morbidities, and other co-morbidities. Patient demographics 
include age, gender, race, and living in a rural area.  Although the claims data do not contain 
direct measurement of complications and co-morbidity, I used specific associated diagnoses as 
proxy. For diabetes, I included the following major complications (Bethel, Sloan, Belsky, & 
Feinglos, 2007): diabetic eye disease (low vision or blindness), chronic renal failure, ESRD, 
gangrene, debridement, amputation, myocardial infarction, congestive heart failure, and stroke. I 
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included an index of diabetic complication in the model, defined as the sum of the number of 
diabetes complications each year. In the eye exam model, the diabetic eye disease was excluded 
from this index but was controlled as an independent binary variable, as having a diabetic eye 
disease is likely to increase the probability of visiting a specialty optometry setting. I also 
identified any insulin use for diabetes in the model, as insulin use typically indicates more severe 
diabetes (Gamble, Simpson, Eurich, Majumdar, & Johnson, 2010; B. A. Young et al., 2008).  I 
used binary indicators for bipolar disorder and schizophrenia, as individuals with those 
conditions might be more likely to use both mental health specialist care and primary care.  
In addition to diabetes complications and other psychiatric co-morbidities, I also included 
general co-morbidities in all analyses. Risk adjustment models with both diabetes-specific and 
generic comorbidity measures have been found to be associated with greater predictive power on 
healthcare expenditures than either diabetes-specific or generic comorbidity measure alone 
(Maciejewski, Liu, & Fihn, 2009). Therefore, the combination of generic and disease-specific 
measures should lead to greater predictive power on probability of receiving different types of 
outpatient care utilization. I used the Chronic Illness and Disability Payment System (CDPS) to 
identify general co-morbidities during the year. There are twenty major categories of diagnoses 
in CDPS (version 6.0), and most of the major categories are further divided into several 
subcategories according to the degree of the increased expenditures associated with the 
diagnoses (Kronick, Gilmer, Dreyfus, & Lee, 2000). I included binary indicators for all 58 
subcategories for current year in the model. 
2.3.3 Empirical specifications 
  To estimate the effect of mental health specialist use on the four outcome measures, the 
empirical estimation takes two different forms of specification: Two-Stage-Least-Squares 
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(2SLS) and Probit-Probit Two-Stage-Residual-Inclusion (2SRI) with raw residuals.  The 2SLS 
estimation takes the following two major equations with i denotes individual, t denotes year 
(2006-2011), and 𝑆𝑖𝑡denotes a binary indicator for mental health specialist use:  
Pr𝑖𝑡(𝑆𝑖𝑡 = 1) = 𝛼0 + 𝛼1 𝐹𝑡 + 𝛾1𝑋𝑖𝑡 + 𝜈𝑖𝑡……(1.1) 
Pr𝑖𝑡(𝐶𝑖𝑡 = 1) = 𝛿0 + 𝜹𝟏 ?̂? + 𝛾2𝑋𝑖𝑡 + 𝑖𝑡……(1.2) 
where ?̂? in equation (1.2) is the predicted probability of mental health specialist use from the first 
stage (equation 1.1). 
The Probit-Probit 2SRI estimation takes the following, 
Pr (𝑆𝑖𝑡 = 1) = Φ(𝛼2 + 𝛼3 𝐹𝑡 + 𝛾3𝑋𝑖𝑡 + 𝜈𝑖𝑡)……(2.1) 
Pr𝑖𝑡(𝐶𝑖𝑡 = 1) = Φ(𝛿2 + 𝜹𝟑 𝑆𝑖𝑡 + 𝛿4 ?̂?𝑖𝑡 + 𝛾4𝑋𝑖𝑡 + 𝑖𝑡)……(2.2) 
where ?̂?𝑖𝑡 in equation (2.2) is the predicted raw residuals from the first stage (equation 2.1), 
measured as the difference between predicted probability of Pr (𝑆𝑖𝑡 = 1) and the actual value of 
𝑆𝑖𝑡. In equation (1)-(2), 𝐹𝑠 denote a vector of instrumental variables. The vector 𝐶𝑖𝑡 denote 
outcomes of interests for person i in year t, including binary indicators for any primary care visits 
during a year, annual lipid test, two A1c tests during a year, and annual eye exam. The 
probability of receiving guideline-concordant care or having any primary care visits is a function 
of mental health specialist use (𝑆𝑖𝑡), and a vector of exogenous variables 𝑋𝑖𝑡, including patient 
demographics and comorbidities. The main parameters of interest are 𝛿1and 𝛿3, the endogenous 
effect. If 𝛿1and 𝛿3 are non-zero and statistically significant, interventions that change mental 
health specialist use would be predicted to spillover on primary care use and the probability of 




If one could reasonably assume that the unobserved severity of chronic conditions or 
personal preferences do not vary during fairly short time periods, including person-level fixed 
effect would alleviate the endogeneity problem.  Therefore, I estimated person-level fixed-effects 
with linear probability models.  Alternatively, if most endogeneity was mostly caused by 
unmeasured time-variant personal preferences or disease severity, fixed effect estimation will not 
appropriately address this omitted-variable bias. Therefore, I also used instrument variables to 
estimate the local average treatment effect (LATE). LATE estimates generated from 
observational data often represent the average effect of treatment for patients with uncertainty in 
treatment choice, or so called “marginal individual,” these are the patients who are most likely to 
have treatment decisions influenced by changes in the instruments (Angrist, Imbens, & Rubin, 
1996; Chapman & Brooks, 2016). For the robustness of estimation, both 2SLS and 2SRI were 
estimated for each outcome. Two-Stage-Least-Squares were estimated both with and without 
person-level fixed effects, while the 2SRI models were only estimated cross-sectionally without 
fixed-effects as non-linear IV models including fixed effects tend to yield inconsistent estimation 
and therefore have different interpretations (Cameron & Trivedi, 2005). All resulting estimations 
for effect of mental health specialist care on outcome of interests (𝛿1 in equation (1.2) and 𝛿3  
(2.2)) are shown in Table 2.3 through Table 2.6. For easier comparison across naïve and IV 
models, results from LPM are presented when 2SLS is the presented, and results from probit 
models are presented when 2SRI is presented.   
Specification tests were performed to assess the strength of the instrumental variables, 
over-identification restriction, and exogeneity.  Strengths of different sets of instrument variables 
were tested with the first stage of 2SLS (LPM) or 2SRI (probit). All over-identifying tests and 
exogeneity tests were performed in LPM-FE models even when the preferred specification is 
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2SRI, as such tests are not available in a non-linear IV models. Sargan-Hansen's tests for over-
identifying restriction were conducted to identify the most appropriate combination of 
instruments for each outcome. Finally, Wooldridge’s score tests were conducted to test the 
exogeneity of mental health specialist use in all models. 
Table 2.2 shows results from specification tests and level of identification. All instrument 
sets are strong predictors of mental health specialist use in the first stage of 2SLS or 2SRI 
estimation (p<0.001) (Table 2.2). The test statistics for the joint F-test reported in lipid test 
model and A1c test model are 67.01 and 83.50, and the Chi-square statistics in eye exam and 
primary care models are 53.83 and 52,92, showing the joint statistical significance of the 
proposed instruments in predicting mental health specialist use. Results from over-identification 
tests showed that mental health specialist use rate and HPDS mental health specialist supply 
together are jointly validly excluded from the second stage of estimating annual lipid test; mental 
health specialist use rate and Medicaid mental health specialist supply are jointly valid 
instruments for estimating A1c tests; HPDS mental health specialist supply and Medicaid mental 
health specialist supply are jointly valid instruments for estimating both probabilities of having 
an eye exam and any primary care visits. Additionally, the rejected exogeneity test in all 
specifications (p<0.001) indicates endogeneity of mental health specialist care.       
Three sets of sensitivity analyses were conducted. First, to examine the influence of 
unmeasured depression severity, three depression care utilization variables from the prior year 
(lagged)--hospitalization for depression, having any antidepressant use, and having any 
psychotherapy-were included as covariates. Because of the reliance on prior year’s data for this 
model, including lags excluded 29.32% of the original sample and reduced the estimation sample 
to 53,977.  Results from analyses on this subsample are similar to the original results except both 
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estimates of mental health specialists on lipid and A1c tests from the 2SLS-fixed effect models 
became insignificant. Second, I restricted the estimation sample to individuals who were enrolled 
in Medicaid for at least 9 months during a year. This enrollment restriction excluded 16.79% of 
the original estimation sample, and the results are similar to the original estimates, in terms of the 
magnitude and significance. Additionally, it is possible that treatment choices for mental health 
specialist care between individuals with and without severe mental illness are heterogeneous. 
Therefore, separate analyses were also conducted on the subgroup without severe mental illness 
(sample size 51,950). Overall, results on all those different subsamples are very similar to those 
on the full sample and therefore are not separately reported but available upon request. 
 
2.4 Results  
Table 2.3 presents estimates of the differential effect of mental health specialist use on 
the expectation of receiving an annual lipid test. In Column (1) and (2), the LPM model and 
LPM fixed effect model both predict a positive association between mental health specialist use 
and receiving annual lipid test. Both the IV models with and without fixed effects (Column (3) 
and (4)), however, predict the effect in an opposite direction. The preferred specification 
(Column (4)) shows that, with endogeneity adjusted by valid instruments and person fixed 
effects, mental health specialist use is found to induce a significant 44.3 percentage point 
reduction in the expected probability of receiving an annual lipid test. The 2SLS without fixed 
effects model (Column (3)) also shows a similar negative differential effect. This result suggests 
that for a marginal individual who has co-occurring diabetes and depression and would increase 
their use of mental health specialist care due to the changes in either local preference or higher 
supply of mental health specialist, receiving mental health specialist care will decrease her 
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probability of receiving an annual lipid test for guideline-concordant diabetes management. 
Further, the differences in results from fixed effect models with IV and without IV (Column (3) 
and Column (4)) implied that the major causes of endogeneity in estimating receiving lipid tests 
are possibly time-variant. For individuals who were diagnosed with severe mental illness 
(bipolar disorder or schizophrenia) during the current year, the probability of receiving a lipid 
test increases by 3.6 percentage points compared to those without any severe mental illness.   
Table 2.4 presents parameter estimation for effects of mental health specialist use and 
other controlled variables on expectation of receiving at least two A1c tests per year. The 2SLS 
with fixed effect models reports a significant negative effect with a magnitude of 31.5 percentage 
points (Column (4)). Note that similar to the lipid outcome model, result from IV models show 
the effect of mental health specialist care in the opposite direction of the effect reported by OLS 
model (Column (1)) and LPM fixed effect model (Column (2)).  This result suggests that for an 
individual with co-occurring diabetes and MDD who would increase use of mental health 
specialist care due to the changes in either local preference or higher supply of mental health 
specialist, receiving mental health specialist care will decrease her probability of receiving at 
least two A1c tests during a year.  
Table 2.5 shows results for estimating differential effect of mental health specialist as 
well as marginal effects of other variables on receiving annual eye exam. After adjusting for 
endogeneity with two instruments, the 2SRI model finds strong positive differential effects as 5.2 
percentage points (Column (3)). Note that LPM fixed effect model in Column (2) also shows a 
significant positive effect of mental health specialist use. Overall, mental health specialist use 
increases probability of receiving an annual eye exam among those marginal individuals who 
would change their mental health specialist use for a change in local supply. Having any insulin 
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use or having any diabetic eye disease both increase probability of receiving an eye exam 
significantly. The number of diabetic complications is negatively affecting receiving an annual 
eye exam.  
Table 2.6 presents the results of the impact of mental health specialist use and other 
controlled variables on the probability of having any primary care visits. In model 1 of Table 2.3, 
the naïve probit estimation shows that mental health specialist use is associated with 1.8 
percentage point increase in probability of having any primary care visit. The LPM fixed effect 
model shows a slightly lower differential effect of mental health specialist use as 1.5 percentage 
points. The 2SRI estimation indicates mental health specialist use leads to a much larger positive 
differential effect as a 14.4 percentage point increase on probability of visiting a primary care 
provider. Overall, the mental health specialist use leads to a higher probability of having any 
primary care visits, and the effect is slightly smaller after the potential endogeneity is adjusted.  
Further, as 2SRI estimation shows, older age leads to decrease in probability of having any 
primary care visits, but the magnitude is fairly small as 0.2 percentage points. Additionally, 
being a male, an African American, and living in an urban area all decrease probability of having 
any primary care visits. 
 
2.5 Discussion  
Among patients with co-occurring diabetes and MDD, mental health specialist use 
decreased the probabilities of receiving two guideline-recommended primary care-based tests: 
annual lipid test and at least two A1c tests in a year, even after adjusting for diabetes 
complications and other co-morbidities. This implies that although such patients who go to a 
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mental health specialist also have higher likelihood of connecting with a primary care provider, 
they are less likely to be guideline-concordant on diabetes care at primary care.  
There are several possible explanations for this surprising finding.  First, it is possible 
that patients are substituting diabetes care with depression care. From a patient’s perspective, 
treating MDD at mental health specialty might lead to less available time for diabetes follow-up 
care at primary care. A patient’s limited time budget could lead to a crowding out effect of 
mental health specialty care on diabetes management. Further, although the current study shows 
that patients with mental health specialist care are more likely to visit a primary care physician, 
physician visits do not assure that patients receives recommended services. A provider may fail 
to follow the diabetes guideline by only responding to immediate concerns that a patient made 
the visit for. Alternatively, once an individual with co-occurring diabetes and MDD decides to 
seek mental health specialist care, the primary care physician might decide to address only one 
condition and the depression treatment or focus crowds out staying on diabetes quality metrics at 
primary care, as the competing demand model suggested (Nutting et al., 2000; Rost et al., 2000). 
Some ad hoc analyses on the number of primary care visits I conducted showed that mental 
health specialist care does not increase number of primary care visits among those with at least 
one primary care visit. This might imply that without additional number of visits, the dynamic 
and focus of primary care visits became a critical factor for receipt of guideline-concordant 
diabetes care.  
Seeing a mental health specialist has been shown to increase the rate of having annual 
eye exam among individuals with co-occurring diabetes and depression. The utilization rate of an 
annual eye exam is low (17.6% for the general sample), consistent with what has been reported 
in other NC Medicaid populations (Domino et al., 2014; Olesiuk et al., 2016). There are several 
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pathways that could lead to this positive effect of mental health specialist. First, an eye exam is 
usually performed in a specialty setting that does not provide depression care. It is possible that 
mental health specialists provide better management of depression than primary care, and 
therefore increase a patient’s willingness to visit an ophthalmology specialty. One might argue 
that individuals in an area with higher supply of mental health specialist usually have better 
access to other specialists and therefore are likely to visit those specialists; however, such an 
omitted-variable bias led by better access to other specialists has been minimized in instrumental 
variable analysis. 
The instrumental variables results have important policy implications. First, increase in 
local supply of mental health specialist will increase mental health specialist use for MDD 
among Medicaid beneficiaries with co-occurring diabetes and depression. Such increase in 
mental health specialist use might increase probability of getting an annual eye exam, which is 
critical in preventing diabetic retinopathy. However, those health policies might succeed at the 
price of lower level of adherence to some primary care based diabetes care.  
In light of the shortage of mental health specialists and the shifting of treatment modality, 
many studies have suggested that depression is a chronic illness that can be effectively treated in 
primary care settings (Ford et al., 2002). That does not necessary imply, however, that primary 
care providers are able to step in and fill the roles of absent mental health specialists. Future 
areas of research exist to what is the appropriate role of mental health specialist in treating 
depression, especially in primary care settings.  
Overall, the present study implies that any policy aiming to increase mental health 
specialist use by increasing the local mental health specialist supply should consider this 
population’s comprehensive care needs, especially among individuals with co-occurring diabetes 
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and depression. In the era of promoting personalized and patient-centered care, this study 
informs the need to further examine benefits of integrating behavioral healthcare and physical 
health care of individuals with multiple chronic conditions. 
While this paper is able to address many analytical issues in estimating the effect of 
mental health specialist use on diabetes care, several limitations are acknowledged. First, caution 
should be made when interpreting this study’s findings, as instrument variable analysis applies to 
“marginal individual.” In the context of this study, marginal individuals are those Medicaid 
beneficiaries whose increased use of mental health specialist care was influenced by the changes 
in either local preference or higher supply of mental health specialist. The study results will not 
apply to individuals who change their behavior due to other reasons.  Second, my analysis only 
focuses on Medicaid enrollees, and is not generalizable to adults that may be uninsured or have 
other types of insurance. Also, although every effort has been made to identify clinical 
information through diagnosis and procedure coding, some of the observed differences between 
recommended and actual care might have been explained with clinical information not available 
in claims data sets (Kerr et al., 2003). For example, glycemic level is not observed in claims data. 
Individuals with good glycemic control might be less likely to be advised by their primary care 
providers for follow-up diabetes checks. Without such information, the negative effect of mental 
health specialist care could be over-estimated. Finally, it is not possible to follow all types of 
recommendations specified in the guidelines for my analysis, as certain services, such as foot 
exams, were not billed separately from physician visits. Nevertheless, even with the limitations 
of the study, the evidence is still relatively strong, showing that mental health specialist use 




2.6 Conclusion  
In this paper, I use an instrumental variables/fixed effects methodology that compares 
outcomes of diabetes care between Medicaid beneficiaries who did or did not visit a mental 
health specialist for their MDD. Overall, this study found that with mental health specialist 
supply and local mental health specialist use as instruments, mental health specialist care 
decreases the probability of receiving regular lipid test and two regular A1c checks, but increases 
the probability of having at least one primary care visit and getting an annual eye exam. These 
effects hold true even when the analyses were conducted on several different restricted 
subsamples.  
This is an opportune time to examine the “spillover” effects of mental health specialist 
care and quality of care among individuals with multiple chronic conditions, as the Patient 
Protection and Affordable Care Act provides new opportunities for integrating behavioral 
healthcare and physical health care of individuals with multiple chronic conditions (US 
Department of Health and Human Services, 2010). As the number of patients with multiple 
chronic conditions in the US will grow substantially and mental health specialty supply is 
predicted to remain low, this study addresses the most critical aspect of the mental health 
specialist care issues among a specific complex patient population and brings important policy 
implications. Findings from this study suggest that for North Carolina Medicaid beneficiaries 
with co-occurring diabetes and MDD, seeking treatment from mental health specialists might 
lead to a higher level of receiving any eye exam but a lower level of guideline-concordant 
diabetes care in other two indicators. This implies that any policy aiming to improve mental 
health care delivery also needs to consider the spillover effect of mental health care on other co-
occurring conditions. This implication is important as comorbidity between diabetes and MDD is 
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common (Moussavi et al., 2007; Wells, Rogers, Burnam, Greenfield, & Ware, 1991). 
Specifically, people with MDD had 25%-50% higher prevalence of diabetes than general 
population (Wells et al., 1991). Future areas of research exist to carefully evaluate whether 
patients with multiple chronic conditions would benefit more from mental health specialist care 
in a coordinated, comprehensive, and patient-centered care setting.  Findings will inform policy 
programs designed to allocate mental health specialist care more efficiently and to reform mental 





Table 2.1 Summary Statistics on Annual Observations 
    Mental Health Specialist Use 
 
All Yes No P-
value¶  (NT=76,369) (NT=23,832) (NT=52,537) 
Outcome 
    
Any Primary care visit (%) 72.62 86.43 66.36 <0.001 
Any lipid test annually (%) 58.04 67.04 53.96 <0.001 
Two or more A1c tests annually (%) 39.59 47.68 35.92 <0.001 
Any eye exam annually (%) 17.62 27.49 13.14 <0.001 
 
    
Patient Characteristics 
    
Age 44.81 44.59 44.91 <0.001 
Female (%) 77.67 78.08 77.49 0.073 
Race 
   
<0.001 
  African American (%) 41.49 42.67 40.96 
 
  White (%) 51.82 52.18 51.66 
 
  Other race (%) 6.91 5.42 7.59 
 
Urban (%) 78.58 79.89 78.01 <0.001 
Number of months of Medicaid Enrollment (1-12) 10.68 11.38 10.36 <0.001 
 
    
Clinical Characteristics 
    
Total number of diabetes complication (0-9) 0.52 0.53 0.52 0.005 
Total number of diabetes complication, exclude 
diabetic eye disease (0-8) 
0.29 0.27 0.30 <0.001 
  Diabetic eye disease (%) 23.60 26.61 22.23 <0.001 
  Gangrene (%) 2.47 2.66 2.38 0.022 
  Debridement (%) 2.22 2.19 2.24 0.650 
  Amputation (%) 0.78 0.72 0.81 0.186 
  Chronic renal failure (%) 6.06 6.22 5.99 0.228 
  End Stage Renal Disease, ESRD (%) 0.90 0.71 0.99 <0.001 
  Myocardial infarction (%) 3.89 3.55 4.05 0.001 
  Congestive heart failure (%) 9.13 7.99 9.65 <0.001 
  Stroke (%) 3.18 2.68 3.41 <0.001 





    Mental Health Specialist Use 
 
All Yes No P-
value¶  (NT=76,369) (NT=23,832) (NT=52,537) 
 
    
Severe mental illness (%) 20.19 40.20 11.11 <0.001 
¶ Chi-square tests were performed for categorical variables and T-tests were performed for continuous variables. Severe mental illness includes schizophrenia 













Level of identification and 
Instruments 









Overidentified. IV: MHS use 
rate, HPDS MHS supply 
F(2, 76296)=67.01** 𝜒1
2 (1)=1.04 𝜒1
2 (1)=6.95** 2SLS-FE 
A1c test 
Overidentified. IV: MHS use 
rate, Medicaid MHS supply 
F(2, 76296)=83.50** 𝜒1
2 (1)=0.13 𝜒1
2 (1)=5.54* 2SLS-FE 
Eye exam 
Overidentified. IV: Medicaid 




2 (1)=75.89** 2SRI-raw 
Any PCP visit 
Overidentified. IV: Medicaid 








2SLS: Two stage least square. 2SRI-raw: Two stage residual inclusion with raw residuals. FE: fixed effect. MHS: mental health specialist. HPDS: North Carolina 
Health Profession Data System. # F-statistic for LPM first stage and Chi^2 for Probit first stage. § Sargan-Hansen's test is performed with 2SLS-FE. 








Table 2.3 Selected Average Marginal Effect Estimations on Probability of Receiving Annual Lipid Test 
  (1) (2) (3)  (4) 
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 Fixed Effect F-statistic (Ho: all u_i=0)    1.62 **    1.42** 
MHS: mental health specialist. LPM: linear probability model. FE: fixed effect. 2SRI: two stage residual inclusion. In all models, other control variables not 
reported include year dummy variables (2006-2011) and CDPS indicators (58 dummy variables). Robust standard errors are estimated in all linear models. 





Table 2.4 Selected Average Marginal Effect Estimations on Probability of Receiving Two A1c Tests in A Year 
  (1) (2) (3) (4) 
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 Fixed Effect F-statistic (Ho: all u_i=0)    1.73 **   1.60** 
MHS: mental health specialist. LPM: linear probability model. FE: fixed effect. 2SLS: two stage least square. In all models, other control variables not reported 
include year dummy variables (2006-2011) and CDPS indicators (58 dummy variables). Robust standard errors are estimated in all linear models. Severe mental 
illness includes schizophrenia and bipolar disorder. *p<=0.05 **p<0.01 
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Table 2.5 Selected Average Marginal Effect Estimations on Probability of Receiving Annual Eye 
Exam 
 
  (1) (2) (3) 
 
Naïve Probit LPM FE 2SRI-raw 
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Fixed Effect F-statistic (Ho: all u_i=0)    1.07 **   
MHS: mental health specialist. LPM: linear probability model. FE: fixed effect. 2SRI: two stage residual inclusion. 
In all models, other control variables not reported include year dummy variables (2006-2011) and CDPS indicators 
(58 dummy variables). Robust standard errors are estimated in fixed effect model. Standard errors are estimated with 
delta-method for differential effect estimation in 2SRI model. Severe mental illness includes schizophrenia and 




Table 2.6 Selected Average Marginal Effect Estimations on Probability of Having Any Primary 
Care Visit 
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Fixed Effect F-statistic (Ho: all u_i=0)    1.69 **   
MHS: mental health specialist. LPM: linear probability model. FE: fixed effect. 2SRI: two stage residual inclusion. 
In all models, other control variables not reported include year dummy variables (2006-2011) and CDPS indicators 
(58 dummy variables). Robust standard errors are estimated in fixed effect model. Standard errors are estimated with 
delta-method for differential effect estimation in 2SRI model. Severe mental illness includes schizophrenia and 








Ali, S., Stone, M. A., Peters, J. L., Davies, M. J., & Khunti, K. (2006). The prevalence of co-
morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. 
Diabetic Medicine : A Journal of the British Diabetic Association, 23(11), 1165–73. 
http://doi.org/10.1111/j.1464-5491.2006.01943.x 
American Psychiatric Association. (2010). Practice guideline for the treatment of patients with 
major depressive disorder. 
Angrist, J. D., Imbens, G. W., & Rubin, D. B. (1996). Identification of causal effects using 
instrumental variables. Journal of the American Statistical Association, 91(434), 444–455. 
http://doi.org/10.2307/2291629 
Banta, J. E., Morrato, E. H., Lee, S. W., & Haviland, M. G. (2009). Retrospective analysis of 
diabetes care in california medicaid patients with mental illness. Journal of General 
Internal Medicine, 24(7), 802–808. http://doi.org/10.1007/s11606-009-0994-9 
Basu, A., Heckman, J. J., Navarro-Lozano, S., & Urzua, S. (2007). Use of instrumental variables 
in the presence of heterogeneity and self-selection: an application to treatments of breast 
cancer patients. Health Economics, 16, 1133–1157. http://doi.org/10.1002/hec.1291 
Beckles, G. L., Engelgau, M. M., Narayan, K. V., Herman, W. H., Aubert, R. E., & Williamson, 
D. F. (1998). Population-Based Assessment of the Level of Care Among Adults With 
Diabetes in the U.S. Diabetes Care, 21(9), 1432–1438. 
http://doi.org/10.2337/diacare.21.9.1432 
Bethel, M. A., Sloan, F. A., Belsky, D., & Feinglos, M. N. (2007). Longitudinal Incidence and 
Prevalence of Adverse Outcomes of Diabetes Mellitus in Elderly Patients. Archives of 
Internal Medicine, 167, 921–927. 
Cameron, A. C., & Trivedi, P. K. (2005). Microeconometrics-Methods and Applications. 
Chapman, C. G., & Brooks, J. M. (2016). Treatment effect estimation using nonlinear two-stage 
instrumental variable estimators: another cautionary note. Health Services Research, 
51(6), 2375–2394. http://doi.org/10.1111/1475-6773.12463 
De Groot, M., Anderson, R. J., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001). 
Association of Depression and Diabets Complications: A meta-Analysis. Psychosomatic 
M, 63(4), 619–630. Retrieved from 
http://journals.lww.com.libproxy.lib.unc.edu/psychosomaticmedicine/Abstract/2001/0700
0/Association_of_Depression_and_Diabetes.15.aspx 
Desai, M. M. (2002). Mental disorders and quality of diabetes care in the veterans health 




Domino, M. E., Beadles, C. a, Lichstein, J. C., Farley, J. F., Morrissey, J. P., Ellis, A. R., & 
Dubard, C. A. (2014). Heterogeneity in the quality of care for patients with multiple 
chronic conditions by psychiatric comorbidity. Medical Care, 52 Suppl 3(3), S101-9. 
http://doi.org/10.1097/MLR.0000000000000024 
Druss, B. G., Zhao, L., Cummings, J. R., Shim, R. S., Rust, G. S., & Marcus, S. C. (2012). 
Mental comorbidity and quality of diabetes care under medicaid. Medical Care, 50(5), 
428–433. http://doi.org/10.1097/MLR.0b013e318245a528 
Eaton, W. W., Armenian, H., Gallo, J., Pratt, L., & Ford, D. E. (1996). Depression and risk for 
onset of type II diabetes. A prospective population-based study. Diabetes Care, 19(10), 
1097–1102. http://doi.org/10.2337/diacare.19.10.1097 
Egede, L. E., Ellis, C., & Grubaugh, A. L. (2009). The effect of depression on self-care 
behaviors and quality of care in a national sample of adults with diabetes. General 
Hospital Psychiatry, 31(5), 422–7. http://doi.org/10.1016/j.genhosppsych.2009.06.007 
Egede, L. E., Nietert, P. J., & Zheng, D. (2005). Heart Disease Mortality Among Adults. 
Diabetes Care, 28(6), 1339–1345. 
Ell, K., Katon, W., Xie, B., Lee, P.-J., Kapetanovic, S., Guterman, J., & Chou, C.-P. (2010). 
Collaborative care management of major depression among low-income, predominantly 
Hispanic subjects with diabetes: a randomized controlled trial. Diabetes Care, 33(4), 706–
13. http://doi.org/10.2337/dc09-1711 
Ellis, A. R., Konrad, T. R., Thomas, K. C., & Morrissey, J. P. (2009). County-level estimates of 
mental health professional supply in the United States. Psychiatric Services (Washington, 
D.C.), 60(10), 1315–1322. http://doi.org/10.1176/appi.ps.60.10.1315 
Ettner, S. L., Hermann, R. C., & Tang, H. (1999). Differences between generalists and mental 
health specialists in the psychiatric treatment of Medicare beneficiaries. Health Services 
Research, 34(3), 737–60. 
Ford, D. E., Pincus, H. A., Unutzer, J., Bauer, M. S., Gonzalez, J. J., & Wells, K. B. (2002). 
Practice-based interventions. Mental Health Service Research, 4(4). 
Gamble, J.-M., Simpson, S. H., Eurich, D. T., Majumdar, S. R., & Johnson, J. A. (2010). Insulin 
use and increased risk of mortality in type 2 diabetes: a cohort study. Diabetes, Obesity 
and Metabolism, 12, 47–53. 
Gonzalez, J. S., Safren, S. a., Delahanty, L. M., Cagliero, E., Wexler, D. J., Meigs, J. B., & 
Grant, R. W. (2008). Symptoms of depression prospectively predict poorer self-care in 
patients with type 2 diabetes. Diabetic Medicine, 25(9), 1102–1107. 
http://doi.org/10.1111/j.1464-5491.2008.02535.x 
Harman, J. S., Scholle, S. H., Ng, J. H., Pawlson, L. G., Mardon, R. E., Haffer, S. C., … 
Bierman, A. S. (2010). Association of health plans’ Healthcare Effectiveness Data and 
 
51 
Information Set (HEDIS) performance with outcomes of enrollees with diabetes, 48(3), 
217–223. 
Katon, W. J., Von Korff, M., Lin, E. H. B., Simon, G., Ludman, E., Russo, J., … Bush, T. 
(2004). The Pathways Study: a randomized trial of collaborative care in patients with 
diabetes and depression. Archives of General Psychiatry, 61(10), 1042–9. 
http://doi.org/10.1001/archpsyc.61.10.1042 
Katon, W., Maj, M., & Sartorius, N. (2011). Depression and Diabetes. John Wiley & Sons. 
Katz, S. J., Kessler, R. C., Lin, E., & Wells, K. B. (1998). Medication management of depression 
in the United States and Ontario. Journal of General Internal Medicine, 13(2), 77–85. 
Kerr, E. a, Smith, D. M., Hogan, M. M., Hofer, T. P., Krein, S. L., Bermann, M., & Hayward, R. 
a. (2003). Building a better quality measure: are some patients with “poor quality” 
actually getting good care? Medical Care, 41(10), 1173–82. 
http://doi.org/10.1097/01.MLR.0000088453.57269.29 
Kronick, R., Gilmer, T., Dreyfus, T., & Lee, L. (2000). Improving health-based payment for 
Medicaid beneficiaries: CDPS. Health Care Financing Review, 21(3), 29–64. 
Lambert, D., Agger, M., & Hartley, D. (1999). Service use of rural and urban Medicaid 
beneficiaries suffering from depression: the role of supply. The Journal of Rural Health : 
Official Journal of the American Rural Health Association and the National Rural Health 
Care Association, 15(3), 344–355. http://doi.org/10.1111/j.1748-0361.1999.tb00756.x 
Lin, E. H. B., Katon, W., Korff, M. Von, Rutter, C., Simon, G. E., Oliver, M., … Young, B. 
(2004). Relationship of depression and diabetes self-care, medication adherence, and 
preventive care. Diabetes Care, 27(9), 2154–2160. 
http://doi.org/10.2337/diacare.27.9.2154 
Lustman, P. J., Anderson, R. J., Freedland, K. E., De Groot, M., Carney, R. M., & Clouse, R. E. 
(2000). Depression and poor glycemic control: A meta-analytic review of the literature. 
Diabetes Care, 23(7), 934–942. http://doi.org/10.2337/diacare.23.7.934 
Maciejewski, M., Liu, C.-F., & Fihn, S. D. (2009). Performance of comorbidity, risk adjustment , 
and functional status measures in expenditure prediction for patients with eiabetes. 
Diabetes Care, 32(1), 75–80. http://doi.org/10.2337/dc08-1099.The 
Merwin, E., Hinton, I., Dembling, B., & Stern, S. (2003). Shortages of rural mental health 
professionals. Archives of Psychiatric Nursing, 17(1), 42–51. 
http://doi.org/10.1053/apnu.2003.1 
Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V., & Ustun, B. (2007). Depression, 
chronic diseases, and decrements in health: results from the World Health Surveys. 
Lancet, 370(9590), 851–8. http://doi.org/10.1016/S0140-6736(07)61415-9 
 
52 
Ng, B., Bardwell, W. A., & Camacho, A. (2002). Depression treatment in rural california: 
preliminary survey of nonpsychiatric physicians. The Journal of Rural Health, 18(4), 556–
562. 
Nutting, P. A., Rost, K., Smith, J., Werner, J. J., & Elliot, C. (2000). Competing demands from 
physical problems: effect on initiating and completing depression care over 6 months. 
Archives of Family Medicine, 9(10), 1059–1064. 
http://doi.org/10.1001/archfami.9.10.1059 
Olesiuk, W. J., Farley, J. F., Domino, M. E., Ellis, A. R., Morrissey, J. P., Lichstein, J. C., … 
Dubard, C. A. (2016). Do medical homes offer improved diabetes care for medicaid 
enrollees with co-occurring schizophrenia? Journal of Health Care for the Poor and 
Underserved. 
Olfson, M., Marcus, S. C., Druss, B. G., Elinson, L., Tanielian, T., & Pincus, H. A. (2002). 
National trends in the outpatient treatment of depression. JAMA: The Journal of the 
American Medical Association, 287(2), 203–209. http://doi.org/10.1001/jama.287.2.203 
Peters, A. L., Legorreta, A. P., Ossorio, R. C., & Davidson, M. B. (1996). Quality of outpatient 
care provided to diabetic patients: a health maintenance organization experience. Diabetes 
Care, 19(6), 601–606. http://doi.org/10.2337/diacare.19.6.601 
Pratt, L. A., & Brody, D. J. (2008). Depression in the United States household population, 2005-
2006. NCHS Data Brief, (7). 
Pratt, L. A., & Brody, D. J. (2014a). Depression and obesity in the U. S. adult household 
population, 2005– 2010. NCHS data brief. Hyattsville, MD. 
Pratt, L. A., & Brody, D. J. (2014b). Depression in the U. S. household population, 2009–2012. 
NCHS data brief. Hyattsville, MD. Retrieved from 
http://www.cdc.gov/nchs/data/databriefs/db172.pdf 
Richman, E., Fraher, E., & Gaul, K. (2015). The North Carolina mental health and substance 
abuse workforce. Retrieved from http://www.shepscenter.unc.edu/wp-
content/uploads/2015/07/NCIOM-SHEPS-MHSA-revMap1.pdf 
Richardson, L. K., Egede, L. E., Mueller, M., Echols, C. L., & Gebregziabher, M. (2008). 
Longitudinal effects of depression on glycemic control in veterans with Type 2 diabetes. 
General Hospital Psychiatry, 30(6), 509–514. 
http://doi.org/10.1016/j.genhosppsych.2008.07.001 
Rost, K., Nutting, P., Smith, J., Coyne, J. C., Cooper-Patrick, L., & Rubenstein, L. (2000). The 
role of competing demands in the treatment provided primary care patients with major 




Sambamoorthi, U., Olfson, M., Wei, W., & Crystal, S. (2006). Diabetes and depression care 
among medicaid beneficiaries. Journal of Health Care for the Poor and Underserved, 
17(1), 141–161. http://doi.org/10.1353/hpu.2006.0034 
Sloan, F. A., Bethel, M. A., Lee, P. P., Brown, D. S., & Feinglos, M. N. (2004). Adherence to 
guidelines and its effects on hospitalizations with complications of type 2 diabetes. The 
Review of Diabetic Studies, 1(1), 29–38. 
Stefos, T., Burgess, J. F., Cohen, J. P., Lehner, L., & Moran, E. (2012). Dynamics of the mental 
health workforce: investigating the composition of physicians and other health providers. 
Health Care Management Science, 15(4), 373–84. http://doi.org/10.1007/s10729-012-
9203-1 
Sturm, R., Meredith, L. S., & Wells, K. B. (1996). Provider choice and continuity for the 
treatment of depression. Medical Care, 34(7), 723–734. http://doi.org/10.1097/00005650-
199607000-00005 
Sturm, R., & Wells, K. B. (1995). How Can Care for Depression Become More Cost-effective? 
JAMA, 273(1), 51–58. 
The Healthcare Effectiveness Data and Information Set. (n.d.). Comprehensive Diabetes Care 
(CDC): HEDIS 2009 Volume 2 Technical Update (Vol. 2). Retrieved from 
http://www.ncqa.org/portals/0/PolicyUpdates/HEDIS Technical 
Updates/09_CDC_Spec.pdf 
Thomas, K. C., Ellis, A. R., Konrad, T. R., Holzer, C. E., & Morrissey, J. P. (2009). County-
level estimates of mental health professional shortage in the United States. Psychiatric 
Services, 60(10), 1323–8. http://doi.org/10.1176/appi.ps.60.10.1323 
UK Prospective Diabetes Study (UKPDS) Group. (1998). Intensive blood-glucose control with 
sulphonylureas or insulin compared with conventional treatment and risk of complications 
in patients with type 2 diabetes ( UKPDS 33 ). The Lancet (British Edition), 352, 837–
853. http://doi.org/http://dx.doi.org/10.1016/S0140-6736(98)07019-6 
US Department of Health and Human Services. (2010). Multiple Chronic Conditions - A 
Strategic Framework: Optimum Health and Quality of life for Individuals with Multiple 
Chronic Conditions. Retrieved from http://www.pined.info/pdf/framework/6.pdf 
Vijan, S., Hofer, T. P., & Hayward, R. A. (2000). Cost-Utility Analysis of Screening Intervals 
for Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus. JAMA, 283(7), 889. 
http://doi.org/10.1001/jama.283.7.889 
Wang, P. S., Lane, M., Olfson, M., Pincus, H. A., Wells, K. B., & Kessler, R. C. (2005). Twelve-
month use of mental health services in the United States: results from the National 




Ward, B. W., & Schiller, J. S. (2013). Prevalence of multiple chronic conditions among US 
adults: estimates from the National Health Interview Survey, 2010. Preventing Chronic 
Disease, 10, 1–15. http://doi.org/10.5888/pcd10.120203 
Wells, K. B., Rogers, W., Burnam,  a, Greenfield, S., & Ware, J. E. (1991). How the medical 
comorbidity of depressed patients differs across health care settings: results from the 
Medical Outcomes Study. The American Journal of Psychiatry, 148(12), 1688–1696. 
Wenze, S. J., Gunthert, K. C., & German, R. E. (2012). Biases in Affective Forecasting and 
Recall in Individuals With Depression and Anxiety Symptoms. Personality and Social 
Psychology Bulletin, 38(7), 895–906. http://doi.org/10.1177/0146167212447242 
Young, A. S., Klap, R., Sherbourne, C., & Wells, K. B. (2001). The quality of care for 
depressive and anxiety disorders in the United States. Archives of General Psychiatry, 
58(1), 55–61. http://doi.org/10.1001/archpsyc.58.1.55 
Young, B. A., Lin, E., Von Korff, M., Simon, G., Ciechanowski, P., Ludman, E. J., … Katon, W. 
J. (2008). Diabetes complications severity index and risk of mortality, hospitalization, and 





CHAPTER 3. STUDY 2: THE EFFECT OF MENTAL HEALTH SPECIALIST CARE 
ON GUIDELINE-CONCORDANT DEPRESSION CARE OF ADULTS WITH CO-
OCCURRING MAJOR DEPRESSIVE DISORDER AND DIABETES 
 
3.1 Introduction  
Major depressive disorder (MDD), a serious mood disorder associated with significant 
reductions in physical and social functioning, is one of the most prevalent mental disorders in the 
US (National Institute of Mental Health, 2015). With an estimated 16.1 million adults affected 
by a depressive disorder in a given year, MDD accounted for 6.7% of all adults in the US 
(National Institute of Mental Health, 2015). The prevalence of MDD is higher among individuals 
with diabetes than among those without diabetes with approximately 10% of adults with diabetes 
having co-occurring MDD, and those with diabetes have a twofold-increased odds of developing 
MDD compared to individuals without diabetes (Moussavi et al., 2007; Rubin, Ciechanowski, 
Egede, Lin, & Lustman, 2004). Prior literature has shown that treating MDD improved both 
depression outcomes and diabetic outcomes such as glycemic control (W. J. Katon, Von Korff, et 
al., 2004; P J Lustman, Freedland, Griffith, & Clouse, 2000; Patrick J Lustman, Griffith, Clouse, 
& Kenneth, 1997; Patrick J Lustman, Griffith, Freedland, Kissel, & Clouse, 1998). A more 
recent systematic review further indicated that either psychotherapy or pharmacotherapy had a 
moderate effect on depression symptoms and a small to moderate effect on glycemic control (W. 
Katon, Maj, & Sartorius, 2011). However, the proportion of individuals with MDD receiving 
recommended treatment is still suboptimal. For individuals with MDD but without other co-
morbid conditions, a 2002 survey found that only 71.7% of patients received at least 84 days of 
antidepressant treatment, the recommended minimum length of treatment (Pincus, 2002). 
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Treatment utilization rates are even lower among those with co-morbid diabetes. For example, 
results from a population study found that among insured patients with both diabetes and MDD 
diagnoses, only 32.8% had received either an adequate dose of an antidepressant during at least 
90 days or at least 4 psychotherapy visits during a year (W. J. Katon, Simon, et al., 2004). 
Either mental health specialists or primary care providers can provide depression care. 
Mental health specialists include prescribers such as psychiatrists and psychiatric nurse 
practitioners, as well as non-prescribers, such as psychologists, social workers, family and 
marriage therapists, and counselors. Individuals diagnosed with major depressive disorder are 
recommended to receive antidepressant medication, psychotherapy, or a combination of the two 
modalities (American Psychiatric Association, 2010). However, the treatment modality has been 
shifting towards more pharmacotherapy during the last decade, especially after the introduction 
of selective serotonin reuptake inhibitors (SSRI), a class of antidepressant medications with 
equal efficacy but lower toxicity from prior antidepressants (Olfson et al., 2002). For example, 
among Florida Medicaid beneficiaries, the percentage of adults with MDD who received 
antidepressants increased from 65.1% to 75.2% between 1996 to 2005, and the percentage who 
received psychotherapy for decreased from 56.6% % to 37.5 % during the same time period 
(Fullerton, Busch, Normand, McGuire, & Epstein, 2011). Coupled with the lack of access to 
mental health specialists in many areas and the growing ability of primary care providers in 
managing depression with pharmacotherapy, this treatment modality change has further led to 
the shifting of depression care utilization from mental health specialists, to primary care settings 
(Pirraglia, Stafford, & Singer, 2003). Research using the National Health and Nutrition 
Examination Survey found that during 2005-2006, only 39% of all Americans with severe 
depressive symptoms reported having seen a mental health professional within a year, and this 
 
57 
statistic dropped to 35% during 2009-2012 (Pratt & Brody, 2008, 2014). Similar findings were 
also reported among older adults in the US (Akincigil et al., 2011) 
Whether mental health specialist care provides better quality of depression treatment has 
long been a major interest of research. In 1990, Mechanic argued that psychiatric services 
provided in the primary care sectors may be inappropriate for some patients (Mechanic, 1990), 
but he also recognized the need for further research to enhance knowledge in this research area 
(Mechanic, 1990). Many studies have provided estimates of effect of mental health specialist 
care on rates of adherence to depression treatment among individuals with depression. In the 
Medical Outcomes Study, a quasi-experimental study, patients with MDD or depressive 
symptoms seen by psychiatrists had higher rates of detection and better guideline-concordant 
care utilization, measured by antidepressant use and counseling, than those treated by primary 
care physicians (Sturm, Meredith, & Wells, 1996). In an analysis of the National Comorbidity 
Survey, 29% of individuals with MDD seen by mental health specialists received combination 
therapy (medication and four or more mental health visits), while only 13.8% of those seen by 
general physicians received the same care, and this difference was higher for persons with 
greater severity of illness (Katz, Kessler, Lin, & Wells, 1998). Finally, another quasi-
experimental study that utilized telephone survey examined appropriate care, defined as use of 
either appropriate psychotropic medication or counseling during the prior year, among 
individuals with MDD and anxiety disorders. The study results showed a much higher proportion 
of not receiving appropriate care in those with primary care visits only than in either those with 
mental health specialist visits only or with both types of visits (80.5%, 11.4%, and 10.1%) (A. S. 
Young, Klap, Sherbourne, & Wells, 2001). Note that this study did not separate care for MDD 
from care for anxiety disorders (A. S. Young et al., 2001). These studies, however, did not 
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control for the selection bias into mental health specialist care.  Further, these studies were 
mostly focused on individuals with MDD only.  
The objective of this study is to examine whether the mental health specialist care for 
MDD affects the receipt of guideline-concordant depression care among a population with co-
morbid diabetes.  The current study addresses the gap in the literature with two major strengths. 
First, this study is focused on individuals with co-occurring MDD and diabetes instead of those 
with MDD only. Second, we control for the selection bias into depression treatment modality via 
both person-level fixed effects and instrumental variable methodology in order to compare the 
outcomes of depression care between Medicaid beneficiaries who made different treatment 
choices on mental health specialist use.  To the best of my knowledge, there have been no other 
observational studies examining the effect of mental health specialists on guideline-concordant 
depression care for individuals with co-occurring diabetes. 
 
3.2 Method 
3.2.1 Conceptual framework 
As prior evidence has shown, the marginal benefits of mental health specialist care on 
health could be higher than that of primary care, as mental health specialist care was found 
associated with a higher probability of receiving guideline-concordant depression care in many 
settings (Katz et al., 1998; Sturm et al., 1996; A. S. Young et al., 2001). However, this positive 
effect might be reduced by other factors among individuals with co-occurring diabetes, while 
those individuals often visit primary care providers for diabetes care. The marginal cost of 
depression care provided by a mental health specialist is usually higher than depression care 
provided by their primary care providers, even among well-insured Medicaid populations, due to 
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greater time and travel costs for treatment. The higher marginal cost, in turn, may reduce the 
probability of depression care with a mental health specialist. In sum, although the marginal 
benefits of depression care provided by mental health specialists on health are potentially higher 
than that provided by primary care providers, the marginal costs of mental health specialist visits 
could be higher too. Therefore, the net change on marginal return of mental health specialist care 
is ambiguous and requires empirical investigation. 
3.2.2 Statistical analysis 
Mental health specialist use is subject to potential endogeneity, since decisions to visit a 
mental health specialist could be heavily driven by severity of illness, personal preferences, or 
other unobservable factors that would also affect antidepressant use or psychotherapy visits. 
Therefore, person-level fixed effect and instrumental variable specifications were used to 
mitigate endogeneity bias. The person-level fixed effect will alleviate the endogeneity problem if 
the unobserved severities of chronic conditions or personal preferences do not vary during a 
fairly short period of time. On the other hand, if the endogeneity was mostly caused by 
unmeasured time-variant factors, instrumental variable estimation will result in consistent 
estimates. Overall, one might argue that those who prefer seeing a mental health specialist might 
be more willing to be adherent to depression treatment as well. With person-fixed effect and 
instrument variable estimation, however, the bias led by unobserved personal preferences on 
mental health specialist care and depression care overall should have been eliminated. Two-
Stage-Least-Squares with person-level fixed effect (2SLS-FE) specification is used to estimate 
the local average treatment effect (LATE) of mental health specialist use on the quality of 
depression care received. The LATE estimates in this study represent the average effect of 
mental health specialist use for a “marginal individual” whose decisions on mental health 
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specialist use are most likely influenced by changes in the instruments (Angrist, Imbens, & 
Rubin, 1996; Chapman & Brooks, 2016). The choice to methods for the binary dependent 
variables with a binary endogeneous variable could vary, however, as 2SLS would be the biased. 
Therefore, probit-probit Two-Stage-Residual-Inclusion (2SRI) with raw residuals is also 
estimated. The standard errors around the marginal effects were estimated via bootstrapping with 
1000 iterations.  The 2SRI models were estimated cross-sectionally without fixed-effects as non-
linear instrumental variable models including fixed effects tend to yield inconsistent estimation 
and therefore have different interpretations (Cameron & Trivedi, 2005). 
 Two sets of sensitivity analyses were conducted. First, I restricted the estimation sample 
to individuals who were enrolled in Medicaid for at least 90 days during the first four months of 
the episode, referred to here as the continuously enrolled. This enrollment restriction excluded 
3.94% of the original estimation sample, and the results are similar to the original estimates, in 
terms of the magnitude and significance. Second, it is possible that treatment choices for mental 
health specialist care between individuals with and without severe mental illness are 
heterogeneous. Therefore, separate analyses were also conducted on the subgroup without severe 
mental illness anytime during the year when the depression episode occurred (n= 35,369). As the 
results are also very similar to those on the full sample, they are not separately reported but are 
available upon request. 
3.2.3 Data 
3.2.3.1 Estimation sample and episode creation 
The data in this study come from the North Carolina Medicaid Analytic Extracts (MAX) 
from 2006-2011. These data files contain enrollment information and final action claims for all 
Medicaid fee-for-service beneficiaries in North Carolina. An adult beneficiary is included if she 
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had at least one inpatient or at least two outpatient diagnoses of diabetes and MDD during the 
study period (International Classification of Disease version 9 [ICD-9] code: 250.XX 357.2X, 
362.0X, 366.41 for diabetes and 296.2X, 296.3X, 300.4X, 311.XX for MDD (The Healthcare 
Effectiveness Data and Information Set, n.d.). Individuals with Medicaid and Medicare dual 
coverage were excluded due to the potential for incomplete information on healthcare and 
prescription drug utilization. Finally, individuals were excluded if they were in one of the five 
(of 100) counties where mental health services were carved-out during this time period, as 
mental health care utilization for such patients were incomplete in MAX files. 
Following the previous literature, we identified depression treatment episodes among this 
estimation sample (Busch et al., 2006; Donohue et al., 2004; Teh et al., 2010). An index event to 
begin an observed episode of depression treatment consisted of one of the following: an 
outpatient visit with a MDD diagnosis, an inpatient stay with a MDD diagnosis, or an 
antidepressant prescription. The episode start date is either the first service beginning date if the 
episode starts with an outpatient visit or an inpatient stay, or the first medication prescribed date 
if the episode starts with an antidepressant prescription, after at least a 60-day gap from a prior 
episode.  An episode is considered terminated when an individual has a gap of at least 60 days in 
depression treatment including antidepressant prescriptions, outpatient visits with a diagnosis of 
MDD, a psychotherapy visit with a diagnosis of MDD, or hospitalization with a diagnosis of 
MDD. In order to identify the receiving of appropriate depression care, the acute phase of an 
episode is defined as the first 114 days and the first 84 days after the index event began for 
observing antidepressant use and psychotherapy use, respectively.  This definition follows the 
Healthcare Effectiveness Data and Information Set and is consistent with other prior studies 
(Schoenbaum et al., 2002; Teh et al., 2010; The Healthcare Effectiveness Data and Information 
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Set, n.d.). Episodes with long-term care facility service use were excluded because those 
beneficiaries are less likely to receive outpatient visit claims during those episodes. To avoid 
censoring problems in examining lengths of an episode, I excluded episodes that began during 
the first 60 days of 2006. I also excluded episodes with acute phases that ended after December 
31, 2011. 
The final estimation sample includes 17,787 unique persons with co-occurring diabetes 
and MDD during 2006-2011 (Table 3.1). The average age was 45, 22% of the sample were male, 
41% were African American, and 79% lived in an urban area. This estimation sample 
contributed 43,822 depression episodes to the analysis, with 10,715 unique individuals having 
more than one episode during the study period.  
3.2.3.2 Key measures 
The dependent variables are three measures of guideline-concordant depression care 
during the acute phase of a depression episode. The adequate antidepressant use is defined as 
whether an individual had at least 84 days coverage of antidepressant prescription during the first 
114 days of a depression treatment episode. This definition follows the Healthcare Effectiveness 
Data and Information Set (The Healthcare Effectiveness Data and Information Set, n.d.). 
Consistent with other studies for guideline-concordant depression care (Schoenbaum et al., 2002; 
Teh et al., 2010), the adequate psychotherapy use is defined as whether an individual had at least 
4 psychotherapy visits during the first 84 days of a depression treatment episode. If any 
hospitalization occurs during the acute phase of the episode, the length of the acute phase was 
extended in adjustment for the days of hospitalization. Finally, guideline-concordant depression 
care, the major outcome of interest, is defined as either having adequate psychotherapy use or 
adequate antidepressant use during a depression episode. 
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Mental health specialist use is the key independent variable in this study. It is defined as 
whether an individual had visited a mental health specialist during the acute phase of a 
depression treatment episode. A mental health specialist visit was identified as an outpatient 
claim with the provider type coded as a mental health specialist, consisting of a psychiatrist, 
psychologist, psychological associate, mental health nurse practitioner, licensed clinical social 
worker, mental health HMO, Assertive Community Treatment Team, or Critical Access 
Behavioral Health Agencies. Overall, 36 % of the episodes in this study had at least one mental 
health specialist visit during the acute phase.  
3.2.3.3 Other control variables 
Other control variables included patient demographics, other psychiatric co-morbidities, 
diabetes complications, and other co-morbidities during the year when the depression treatment 
episode began. Patient demographics included age, gender, and race. Age was measured at the 
beginning of the episode. Race was categorized as Caucasian, African American, and other 
races. Rural residence, which was found to be negatively associated with the number of mental 
health visits (Lambert, Agger, & Hartley, 1999), was defined as with a binary indicator. Rural 
area is defined according to Rural-Urban Commuting Areas (RUCAs). The RUCA codes classify 
U.S. census tracts using measures of population density, urbanization, and daily commuting 
(United States Department of Agriculture Economic Research Service, 2016). As census tracts 
are not available in MAX data, RUCA codes were identified with zipcode in this study. Area 
with RUCA codes less than 4 is defined as rural.   
Further, I controlled for comorbid conditions that might affect both the probabilities of 
mental health specialist use and depression care receipt. I included binary indicators for severe 
mental illness, including bipolar disorder and schizophrenia, as individuals with those conditions 
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might be more likely to use both mental health specialist care and receive any psychotherapy or 
pharmacotherapy. For diabetes, I created an index of diabetic complications following Bethel 
and colleagues (2007), defined as the total number of diabetes complications as identified in the 
claims data. The index ranges zero to eight by calculating the number of complications among 
the following: diabetic eye disease (low vision or blindness), chronic renal failure, ESRD, 
gangrene, debridement, and amputation, myocardial infarction, congestive heart failure, and 
stroke (Bethel, Sloan, Belsky, & Feinglos, 2007). Additionally, a separate binary indicator for 
any insulin use is also included in the model, as insulin use typically indicates more severe 
diabetes (Gamble, Simpson, Eurich, Majumdar, & Johnson, 2010; B. A. Young et al., 2008).  
Finally, general co-morbidities identified through Chronic Illness and Disability Payment 
System (CDPS) are also included in all analyses. There are twenty major categories of diagnoses 
in CDPS (version 6.0), and most of the major categories are further divided into several 
subcategories according to the degree of the increased expenditures associated with the 
diagnoses (Kronick, Gilmer, Dreyfus, & Lee, 2000). Overall, there are 58 binary indicators for 
all CDPS subcategories controlled in all current analyses. All the comorbidities are identified 
during the beginning year of a depression treatment episode. 
3.2.3.4 Instrumental variables 
Three variables were identified as potential instruments to correct the endogeneity: a 
local preference-based variable determined by the utilization pattern of mental health specialist 
use among Medicaid beneficiaries at the county-level (Basu, Heckman, Navarro-Lozano, & 
Urzua, 2007), the total number of licensed mental health specialists in each county from North 
Carolina Health Professions Data System (HPDS) (Richman, Fraher, & Gaul, 2015), and the 
total number of mental health specialists accepting Medicaid patients. As valid instruments, 
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those instruments should only affect depression care outcomes through mental health specialist 
use and otherwise be independent of guideline-concordant depression care.   The first instrument, 
mental health specialist use rate, is defined as the proportion of all Medicaid beneficiaries who 
had any mental health specialist use during the year at the county-level. The variation in local 
treatment selection is possibly through a historical practice style, which is plausibly independent 
of underlying health, preferences and outcomes of the patients (Basu et al., 2007). The full 
Medicaid sample regardless of diagnosis was used to generate variables reflecting total number 
of Medicaid beneficiaries enrolled by county as well as the proportion of beneficiaries with at 
least one mental health specialist visit at county-level.  
The second instrument, HPDS supply, is a mental health specialist supply measure, 
defined as the total number of psychiatrists and psychologists in a county, comes from North 
Carolina Health Professions Data System (HPDS) (Richman et al., 2015). In theory, the supply 
of mental health specialists affects depression care through affecting mental health specialist use 
only. Due to data availability in HPDS, this measure includes only psychiatrists and 
psychologists, the two major types of mental health specialist (Richman et al., 2015).  
Nevertheless, this measure is likely to reflect the availability of mental health specialist services 
more generally, as indicated by the high correlation between number of psychiatrists, 
psychologists, and other specialists at the county level (Ellis, Konrad, Thomas, & Morrissey, 
2009).  
The third measure, Medicaid mental health specialist supply, is defined as the number of 
mental health specialists that had seen at least one Medicaid beneficiary in a year at the county-
level. A Medicaid provider is identified with a unique provider identifier that had at least one 
claim for a Medicaid beneficiary in a year.  The unique identifiers used are state-assigned 
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Medicaid billing identifiers prior to 2009 and National Provider Identifier (NPI) beginning 2009. 
The Medicaid mental health specialist supply is measured as the total number of Medicaid 
mental health specialists with some Medicaid-billed claims in a year at county-level. Note that a 
provider could be counted more than once as she might be identified from different counties in a 
year. The full sample regardless of diagnosis was used to identify Medicaid mental health 
specialist. All three instruments are appended to the analysis file during the year when a 
depression episode began. 
3.2.4 Specification tests 
  Specification tests were performed to assess the strength of the instrumental variables, 
the over-identifying restriction, and the exogeneity of mental health specialist use. The 
instruments were highly predictive of mental health specialist use in the first stage of 2SLS 
estimation. The test statistics for the joint F-test on all three instruments from the first stage of 
2SLS were greater than 10 (F(3, 43748)=31.36, p<0.001), showing the joint statistical 
significance of the proposed instruments in predicting mental health specialist use (Staiger & 
Stock, 1997; Stock, Wright, & Yogo, 2002). Additionally, Sargan-Henson’s test was conducted 
with the 2SLS-FE specification to test the over-identifying restriction with the three instruments. 
The results showed that this instrument set passed the test of overidentification in all three 
models (χ_2^2  =3.74, 0.87, and 0.53 for antidepressant, psychotherapy, and guideline-
concordant depression care models). Finally, the endogeneity of mental health specialist use was 
tested in each 2SLS-FE model. The test results, however, failed to reject the null hypothesis that 
mental health specialist use is endogeneous, implying that FE specification without IVs might be 
more efficient.  Results from non-IV and IV estimation are all reported. As exogeneity is not 
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rejected in IV specifications, results from linear probability models are also presented. All the 
analyses and specification tests were conducted with Stata 13 (Stata Corp, Texas). 
 
3.3 Results  
On average, nearly 39% of the episodes in the current analysis had adequate 
antidepressant use with a filled prescription for an antidepressant medication for at least 84 days 
during the acute phase, but only less than 11% of the episodes had adequate psychotherapy with 
at least four visits during the first 84 days following the index event for depression (Table 3.1). 
On average, 43% of episodes had guideline-concordant depression care with either adequate 
antidepressant use or adequate psychotherapy use.   
Table 3.2 presents estimates of the differential effect of mental health specialist use on 
the expectation of receiving adequate antidepressant care for depression. The LPM (column (1)) 
predicts that episodes with mental health specialist use are associated with 20.5 percentage point 
increase on probability of adequate antidepressant use. The LPM-FE (column (2)) also predicts 
mental health specialist use leads to a 19.4 percentage point increase on probability of adequate 
antidepressant use. The 2SLS-FE specification (column (3)) further predicts a positive effect by 
21.0 percentage points; however, with a much larger standard deviation estimated from the 
2SLS-FE specification, this effect is insignificant at the 5% level. Note that results from the 
exogeneity test with this 2SLS-FE specification also failed to reject exogeneity. Being one year 
older or female increased the probability of adequate antidepressant use by 0.3% and 2.7%, 
respectively (p<0.01). African Americans and other minorities are significantly less likely to 
receive adequate antidepressant care by 11.5% and 4.2%, respectively (p<0.01). Individuals with 
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more diabetes complications during the episode year are more likely to receive adequate 
antidepressants by1.7% in both LPM-FE and 2SLS-FE specifications (p<0.01).   
Table 3.3 presents estimated effects of mental health specialist use and other controlled 
variables on the expectation of receiving at least four psychotherapy visits during the first 84 
days of a depression episode. The LPM models report a significant positive effect with a 
magnitude of 24.0 percentage points (Column (1)). The LPM-FE model (Column (2)) and 2SRI 
model (Column (3)) also show the same significant positive effect of mental health specialist 
care on receiving adequate psychotherapy. The preferred 2SRI specification reports a differential 
effect of mental health specialist use as 15.4 percentage points. This result suggests that for an 
individual with co-occurring diabetes and MDD who would increase use of mental health 
specialist care due to the changes in either local preference or higher supply of mental health 
specialist, receiving mental health specialist care will increase her probability of receiving at 
least four psychotherapy during the acute phase of a MDD episode by 15.4 percentage points. 
African American and other race are significantly less likely to receive adequate psychotherapy 
by 2.3% and 2.4% (p<0.01), even after controlling for the regional supply of mental health 
specialists. Individuals with one additional diabetes complication during the episode year are 
more likely to receive adequate psychotherapy by 0.6 percentage points (p<0.01).    
The final LPM model reports that mental health specialist use is significantly associated 
with a 28.4 percentage points higher probability of receiving guideline-concordant depression 
care (Table 3.4, Column (1)). After adjusting for the endogeneity led by unobservable time-
invariant factors, the LPM-FE model further predicts a significant and slightly smaller effect as 
26.5 percentage points. After adjusting for the endogeneity with instruments, however, the effect 
became larger as 34.4 percentage points but insignificant at the 5% level with a p-value of 0.166. 
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Note that results from the exogeneity test with this 2SLS-FE specification also failed to reject 
exogeneity. Overall, among individuals with co-occurring diabetes and MDD, mental health 
specialist care increases the probability of receiving guideline-concordant depression care during 
the acute phase of depression. Additionally, being female is more likely to receive guideline-
concordant depression are by 2.7% (p<0.01), while African American and other minorities are 
less likely to receive such care by10.8% and 4.4% (p<0.01). 
 
3.4 Discussion  
This study found a relatively low rate of guideline-concordant depression care during 
acute phase of depression treatment episodes among individuals with co-occurring depression 
and diabetes. On average, only 43% of the analyzed episodes had evidence of guideline-
concordant depression care. This utilization rate is lower than what have been reported for those 
with MDD only, which ranged in prior research from 44.2% to 71.7% (Pincus, 2002; 
Schoenbaum et al., 2002; Teh et al., 2010), and is slightly higher than the utilization rate among 
those with co-occurring MDD and diabetes another study reported as 32.8% (W. J. Katon, Simon, 
et al., 2004). 
Mental health specialist care is found to increase the likelihood of receiving guideline-
concordant care among those with co-occurring diabetes. Specifically, this effect is positive even 
among those who are likely receiving diabetes care from their primary care providers. While 
prior studies on individuals with MDD have demonstrated that mental health specialist care 
might provide better quality of depression care than primary care (Katz et al., 1998; Sturm et al., 
1996; A. S. Young et al., 2001), the current study builds on upon this literature and provide new 
estimates on a more specific population with complex healthcare needs. Further, the positive 
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effect of mental health specialist care holds true across different specifications. These robust 
findings imply the benefit of mental health specialist care on improving quality of depression 
care, despite the potential higher relative cost for visiting a mental health specialist in this more 
primary care based population.  
The instrumental variable estimation also brings important policy implications. The 
results suggest that improvement in quality of depression care could be achieved by increasing 
local supply of mental health specialists, and future policies should aim to trigger supply increase. 
For example, the Psych NP-NC program in North Carolina was launched in 2004 to recruit and 
educate nurses with prescriptive authority so that they can return to their home community or 
county to provide essential psychiatric and mental health assessment and treatment, including 
prescription of psychotropic medications and psychotherapies (Soltis-Jarrett, 2011). The program 
has been successful in targeting a total of 67 counties and graduating 74 new psychiatric nurses 
during 2004-2011(Soltis-Jarrett, 2011). Another way to increase mental health specialist use in 
this population is to increase the number of providers participating in Medicaid. Given the 
current limited supply, telepsychiatry is a potential solution for more mental health specialists to 
deliver certain forms of depression care to Medicaid beneficiaries. Psychiatric consultation and 
follow-up delivered by telepsychiatry has been found to produce clinical outcomes equivalent to 
those achieved by same services provided through face to face, with 10% less cost (O’Reilly et 
al., 2007). However, exploratory analysis in these data shows that utilization rates of 
telepsychiatry are still less than 1% in both Medicaid beneficiaries with co-occurring MDD and 
diabetes as well as all Medicaid beneficiaries in North Carolina. Future targeted efforts are 
needed in identification and dissemination of evidence-based telepsychiatry models.   
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Another important point is that substantial racial disparities were found in the rates of 
receiving adequate antidepressant use, receiving adequate psychotherapy use, and receiving 
overall guideline-concordant depression care. African Americans and other minorities are less 
likely to receiving any adequate depression treatment even after all other important factors are 
controlled. This finding is consistent with what has been reported in another Medicaid population 
(OR=1.04 for not receiving guideline-concordant depression care) (Teh et al., 2010) and 
consistent with the disparities for African-Americans and other minorities in utilization of mental 
health services in representative US population (Cook, Doksum, Chen, Carle, & Alegría, 2013; 
Cook, McGuire, & Miranda, 2007). This study also found that female beneficiaries have higher 
likelihood of receiving appropriate depression care during the acute phase of a depression 
episode, although the effect is much smaller than what have been reported in a prior study that 
examined life-time depression care utilization (OR: 1.89) (Galbaud du Fort, Newman, Boothroyd, 
& Bland, 1999). This observed gender difference could be explained by the notion that women 
are more likely to seek professional help for psychiatric problems (Henderson, Evans-Lacko, & 
Thornicroft, 2013).  
Although many studies have suggested that MDD is a chronic illness that can be 
effectively treated in primary care settings (Ford et al., 2002), the current study finds that, mental 
health specialist care could still improve rates of receiving guideline-concordant depression care, 
even among individuals with co-occurring diabetes and MDD who could be more primary-care 
based due to diabetes management. This positive effect implies the possibility that the clinical 
significance of mental health specialist care on quality of depression care still outweighs the 
potential high marginal cost of visiting a mental health specialist in this specific population.  
Further, our instrumental estimation suggests that such improvement in quality of depression 
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care could be achieved by increasing local supply of mental health specialists. Future research is 
encouraged to identify and evaluate appropriate policies to trigger such changes, especially in 
areas with severe shortage of mental health specialist. 
While this paper is able to address many of the relevant issues in estimating the effect of 
mental health specialist use on depression care, several limitations are acknowledged. First, this 
study was only focused on Medicaid enrollees and services reimbursed by Medicaid; therefore, 
we could not observe depression treatment services provided outside of Medicaid, and our results 
might not be generalizable to adults who are uninsured or have other types of insurance. 
Additionally, it is not possible to address the quality or the content of psychotherapy or mental 
health specialist visit due to data limitations. Finally, due to the lack of clinical information in 
claims data, clinical outcomes of this study population were not observable. Future areas of 
research, therefore, exist to carefully evaluate whether such improvement in quality of 
depression care would alleviate depression symptoms and overall health status.  
Better understanding of the effect of mental health specialist care on the receipt of quality 
care for depression among Medicaid beneficiaries with co-occurring diabetes and MDD will 
allow for more targeted efforts on health policy to improve treatment and outcomes for this 
population. As the number of patients with multiple chronic conditions in the US grows 
substantially and the supply of mental health specialists is predicted to remain low (Anderson, 
2010; Thomas, Ellis, Konrad, Holzer, & Morrissey, 2009), this study brings important policy 
implications for a specific complex population. Findings will also inform policy programs 




Table 3.1 Summary Statistics 
Individual Level Characteristics All 
  (N=17,787) 
Female (%) 74.66 
Race 
 
  Caucasian (%) 52.28 
  African American (%) 41.05 
  Other race (%) 6.87 
Living in a rural area (%) 21.03 
Average number of episodes observed per person 
(1-17, SD) 2.44 (1.74) 
    
 
Acute-Phase Depression Episode Level Characteristics Mental Health Specialist Use 
 
All Yes No 
P-value § 
N (43,822) (15,749) (28,073) 
Depression Care Outcome 
    
At least 84 days of antidepressant during first 114 days 
(%) 
38.67 50.04 32.29 <0.001 
At least 4 psychotherapy during first 84 days (%) 10.96 26.45 2.28 <0.001 
Guideline-concordant depression care (%) 42.55 47.53 35.92 <0.001 
 
    
Episode Characteristics 
    
Age at the beginning of an episode (years, SD) 43.920 43.766 44.008 0.031 
 
(0.054) (0.089) (0.068) 
 
Number of days of Medicaid enrollment within the first 
4 Months (0-124, SD) 
117.87 119.59 116.90 <0.000 
 
(15.91) (11.10) (17.98) 
 
Clinical Characteristics ¶ 
    
Total number of diabetes complication (0-9, SD) 0.5550 0.5316 0.5683 0.009 
 
(0.0039) (0.0061) (0.0050) 
 
 Diabetic eye disease (%) 25.70 27.28 24.81 <0.001 
  Gangrene (%) 2.51 2.25 2.66 0.008 
  Debridement (%) 2.35 2.10 2.49 0.010 
  Amputation (%) 0.98 0.79 1.09 0.003 
  Chronic renal failure (%) 6.25 5.94 6.42 0.047 
  End Stage Renal Disease, ESRD (%) 1.00 0.74 1.15 <0.001 
  Myocardial infarction (%) 4.37 3.76 4.72 <0.001 
  Congestive heart failure (%) 8.94 7.29 9.87 <0.001 
  Stroke (%) 3.40 3.02 3.62 0.001 
Any insulin use (%) 32.30 30.92 33.08 <0.001 
Severe mental illness (%) 19.29 33.49 11.32 <0.001 
Guideline-concordant depression care: At least 84 days of antidepressant and/or at least 4 psychotherapy visits. 
¶Clinical characteristics are measured during the year when the episode began. §Chi-square tests were performed for 
categorical variables and T-tests were performed for continuous variables. Severe mental illness includes 
schizophrenia and bipolar disorder. 
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Table 3.2 Selected Average Marginal Effect Estimations on Probability of Receiving ≥84 Days 
of Antidepressant 
 
  (1) (2) (3) 
 
LPM LPM-FE 2SLS-FE 
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Number of days of Medicaid enrollment within the 
first 4 Months 








Any insulin use 0.0081 
 



























           











R-squared 0.12        
 LPM: linear probability model. 2SLS: two stage least square. FE: fixed effect. Other control variables not reported 
include year dummy variables (2006-2011) and CDPS indicators (58 dummy variables). Robust standard errors are 







Table 3.3 Selected Average Marginal Effect Estimations on Probability of Receiving ≥4 
Psychotherapy 
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LPM LPM-FE 2SRI 
  
 









      


















   
(0.0033) 
 
Race (Reference: White) 
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first 4 Months 












































              











R-squared 0.12           
 LPM: linear probability model. 2SRI: two stage residual inclusion. FE: fixed effect. Other control variables not 
reported include year dummy variables (2006-2011) and CDPS indicators (58 dummy variables). Robust standard 
errors are estimated in linear models with delta-methods. Standard errors for 2SRI were bootstrapped with 1000 
iterations. Severe mental illness includes schizophrenia and bipolar disorder. *p<=0.05 **p<0.01 
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Table 3.4 Selected Average Marginal Effect Estimations on Probability of Receiving Guideline-
concordant Depression Care 
  
  (1) (2) (3) 
 
LPM LPM-FE 2SLS-FE 
  
 









      











Female  0.0266 ** 
    
 
(0.0056) 
     
Race (Reference: White) 
      
  African American -0.1083 ** 
    
 
(0.0048) 
     
  Other race -0.0438 ** 
    
 
(0.0094) 
     













Number of days of Medicaid enrollment within the 
first 4 Months 








Any insulin use 0.0081 
 





























              











R-squared 0.12           
 LPM: linear probability model. 2SLS: two stage least square. FE: fixed effect. Other control variables not reported 
include year dummy variables (2006-2011) and CDPS indicators (58 dummy variables). Robust standard errors are 
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CHAPTER 4. STUDY 3: DOES MENTAL HEALTH SPECIALIST USE AFFECT 
EMERGENCY DEPARTMENT VISITS AND HOSPITALIZATIONS OF ADULTS 
WITH CO-OCCURRING DIABETES AND MAJOR DEPRESSIVE DISORDER? 
 
4.1 Background  
  The growing use of emergency department (ED) services and inpatient care has become 
a leading cost driver in the US health care system (Schuur & Venkatesh, 2012). Nationally, the 
annual number of hospital admissions increased by 15.0% between 1993 to 2006 (Schuur & 
Venkatesh, 2012), and the annual number of ED visits also increased by 23.1% between 1997 
and 2007 (Tang, Stein, Hsia, Maselli, & Gonzales, 2010). Further, individuals with multiple 
chronic conditions are higher utilizers of such tertiary care. A prior study analyzing Medical 
Expenditure Panel Survey (MEPS) in 2009 found that the likelihood of having at least one 
hospital stay or at least one ED visit significantly increased among individuals with more than 
one chronic condition (Machlin & Soni, 2013). 
 Diabetes and major depressive disorder (MDD) are two of most common chronic 
conditions that tend to co-occur and affect each other’s courses (Ali, Stone, Peters, Davies, & 
Khunti, 2006; Eaton, Armenian, Gallo, Pratt, & Ford, 1996; Katon, Maj, & Sartorius, 2011; 
Moussavi et al., 2007; Pratt & Brody, 2014a). Individuals with diabetes are higher utilizers of 
ED and inpatient care than those without diabetes (Dall et al., 2008; Zhou et al., 2015). Major 
depressive disorder is shown to be associated with increased risk of obesity, glycemic level, 
diabetic complications including diabetic retinopathy, nephropathy, neuropathy, microvascular 
complications, and higher mortality among individuals with diabetes (De Groot et al., 2001; 
Eaton et al., 1996; Egede et al., 2005; Knol et al., 2006; Lustman et al., 2000; Pratt & Brody, 
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2014a). Further, MDD leads to higher ED and inpatient care use compared with those who were 
not depressed among those with diabetes (Ciechanowski, Katon, & Russo, 2000; Davydow et al., 
2013; Himelhoch, Weller, Wu, Anderson, & Cooper, 2004; Hutter, Schnurr, & Baumeister, 2010; 
Kalsekar et al., 2006). Among Medicare beneficiaries with diabetes, Himelhoch and colleagues 
found MDD almost doubled the likelihood of using ED services (from 36% to 65%), and 
doubled the likelihood of having inpatient admissions (from 34% to 66%) (Himelhoch et al., 
2004). With the increasing prevalence of diabetes and MDD, the high ED and inpatient services 
use attributed to the population with co-occurring diabetes and MDD has been an emerging 
public health challenge. 
While MDD is now commonly treated in primary care, many individuals with MDD are 
seen by mental health specialists, including prescribers, such as psychiatrists and psychiatric 
nurses, and other non-prescribers, such as psychologists, licensed clinical social workers, family 
and marriage therapists, and counselors. However, over half of U.S. counties have shortages of 
mental health specialists (Merwin, Hinton, Dembling, & Stern, 2003), and about three-quarters 
of U.S. counties were estimated to have a severe shortage of psychiatrists (Thomas, Ellis, Konrad, 
Holzer, & Morrissey, 2009). Guidelines have suggested that individuals diagnosed with major 
depressive disorder be treated with antidepressant medication, psychotherapy, or a combination 
of the two modalities (American Psychiatric Association, 2010). The treatment of MDD, 
however, has been shifting towards more pharmacotherapy at primary care settings since the 
1990s (Akincigil et al., 2011; Ng, Bardwell, & Camacho, 2002; Olfson et al., 2002; Wang et al., 
2005).  Research using the National Health and Nutrition Examination Survey found that during 
2009-2012, only 35% of all Americans with severe depressive symptoms reported having seen a 
mental health specialist within a year (Pratt & Brody, 2014b).   
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Whether mental health specialist care provides better quality of depression treatment has 
long been a major interest of research. Some literature has indicated mental health specialist care 
improves the quality of depression care over other providers among those with MDD only (Katz, 
Kessler, Lin, & Wells, 1998; Sturm, Meredith, & Wells, 1996; A. S. Young, Klap, Sherbourne, 
& Wells, 2001). Patients with MDD seen by psychiatrists were found to have better guideline-
concordant care utilization, measured by antidepressant use and counseling, than those treated by 
primary care physicians in the quasi-experimental Medical Outcomes Study (44% vs 21% for 
antidepressant use, 87% vs 37% for counseling) (Sturm & Wells, 1995). In an analysis of the 
National Comorbidity Survey, a higher proportion of individuals (29%) with MDD seen by 
mental health specialists received medication and four or more mental health visits than those 
seen by general physicians only (13.8%) (Katz et al., 1998).  
Depression severity is associated with higher ED and inpatient care utilization among 
those with diabetes (Ciechanowski et al., 2000). The higher utilization might be resulted from an 
objective worsening glucose control or an increased risk of diabetic complications associated 
with MDD. (De Groot, Anderson, Freedland, Clouse, & Lustman, 2001; Lustman et al., 2000; 
Richardson, Egede, Mueller, Echols, & Gebregziabher, 2008). It might be also a result of a lack 
of adequate outpatient care for diabetes or MDD (Oster & Bindman, 2003). In theory, therefore, 
improvement in depression symptoms through better quality of outpatient depression care could 
lead to lower ED and inpatient care utilization.  However, there is only limited evidence on the 
differences in outcomes of individuals with MDD treated in primary care settings and mental 
health specialty. Results from a recent clinical trial showed that identical remission and response 
rates were achieved in primary and specialty settings when identical care is provided (Gaynes et 
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al., 2008). Regardless, there is still very limited empirical evidence on changes in ED and 
hospitalizations associated with mental health specialist care. 
The objective of this study is to examine whether the use of mental health specialists for 
depression care affects ED visits and hospitalizations. The current study builds on previous 
research to provide further evidence of the role of mental health specialist care on ED visits and 
hospitalizations by addressing the gap in the literature with two major strengths. First, this study 
is focused on individuals with co-occurring MDD and diabetes instead of those with MDD only 
or with diabetes only. Second, the selection bias into depression treatment modality is controlled 
via both instrumental variable methods and panel-data analysis in order to compare the 
utilization outcomes between those who made different treatment choices on mental health 
specialist use.  To the best of my knowledge, this study is the first to model mental health 
specialist use as endogenous with both instrumental variables and panel-data specifications to 




4.2.1 Conceptual framework 
Two types of providers for depression care are considered: mental health specialists and 
primary care providers. The depression care provided by mental health specialists would affect 
ED visits and hospitalizations differently than depression care provided by primary care 
providers, but the differential treatment effect could be in opposite directions.  
ED visit and inpatient service use are reflective of a patient’s health status. Intuitively, for 
patients with confirmed diagnoses of diabetes and MDD, outpatient care could be considered 
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preventive care and lead to better health reflected by less avoidable emergency and inpatient 
service use.  Therefore, we need to examine the health production function. Assuming that an 
aggregate health production function could be expressed as 
𝐻 = ℎ(𝐷1(𝐺, 𝑆), 𝐷2(𝐺, 𝑆); 𝐸)……(1) 
Where G is primary care physician visit count and S is a mental health specialist visit count. E is 
the consumer’s predetermined stock of knowledge or human capital exclusive of health capital. 
𝐷1 is quality of diabetes care, and 𝐷2 is quality of depression care. The total marginal 






































, then mental health specialists are more efficient than primary care providers in terms 
of their marginal contribution to health. Efficient providers are defined as those that provide care 
with fewer inputs (i.e. visits, duration of treatment, or medications) than an inefficient provider 
but achieve the same outcome (Lindrooth et al., 2006; Newhouse, 1996) 
 






































which says the marginal contribution to quality of diabetes care of a primary care visit is larger 
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the marginal benefit to health (measured by ED and inpatient care) of mental health specialist 
use with respect to primary care use is greater than one.  In sum, mental health specialist care 
could decrease ED/hospitalization by increasing the marginal returns to depression care on health. 
While depression severity is associated with higher ED and inpatient care (Ciechanowski et al., 
2000; Gonzalez et al., 2008), the higher quality associated with mental health specialist care 
could lead to lower ED and inpatient care. Therefore, the marginal return to mental health 
specialist care on health production could be higher than that of primary care, and thus could 
lead to lower ED and inpatient care.  
However, it is also possible that mental health specialist care crowds out diabetes care 
due to the emphasis on depression issues in preventive outpatient care (Lin, 2017). The 
crowding-out effect could lead to lower adherence to diabetes care, worse general health 
outcomes, and therefore, higher all-cause ED/hospitalization utilization. Therefore, the effect of 
mental health specialist visits on ED/hospitalizations is ambiguous a priori and an important 
empirical question. 
4.2.2 Empirical specifications 
Mental health specialist use is subject to potential endogeneity since decisions to visit a 
mental health specialist could be heavily driven by severity of illness, personal preferences, or 
other unobservable factors that could also affect ED and inpatient utilization. To estimate the 
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effect of mental health specialist use, two different empirical strategies were employed. First, the 
potential endogeneity of mental health specialist care was addressed by adopting an instrumental 
variable approach. Further, panel-data analyses were conducted to explicitly account for within-
person correlation and time-invariant latent heterogeneity. Outcomes of interest include both the 
probabilities of having any ED/hospitalizations and the total counts of ED visits /hospitalization 
days.  
4.2.2.1 Any ED visits/hospitalization days 
The choice of methods for the binary dependent variables with a binary endogeneous 
variable could vary depending on the rarities of outcomes and treatment. As Two-Stage-Least-
Square (2SLS) could be biased, probit-probit Two-Stage-Residual-Inclusion (2SRI) models with 
raw residuals were also estimated. The standard errors around the marginal effects were 
estimated via bootstrapping with 1000 iterations.  Further, to control for time-invariant 
unobservable factors, Two-Stage-Least-Square (2SLS) specifications with person-level fixed 
effect were also estimated. The 2SRI models were estimated without fixed-effects as non-linear 
instrumental variable models including fixed effects tend to yield inconsistent estimation 
(Cameron & Trivedi, 2005), but was estimated with Generalized Estimating Equations (GEE) to 
account for correlation between different observations within the same individual.   
4.2.2.2 Total ED visits/hospitalization days 
The effects of mental health specialist care on total ED visits and hospitalization days 
were estimated with GEE models with negative binomial distributions, taking into account the 
correlation among different observations across years for the same patient. To further mitigate 
potential endogeneity of mental health specialist care, instrumental variables were used in GEE 
 
90 
models with 2SRI-raw residuals. The standard errors around the marginal effects of all 
instrumental variable models were estimated via bootstrapping with 1000 iterations. 
4.2.2.3 Specification tests 
Specification tests were performed to assess the strength of the combination of the three 
proposed instrumental variables, over-identification restrictions, and exogeneity.  The strength of 
the three instrumental variables was tested in the first stage of 2SRI (probit).  The Chi-square test 
statistic in the first stage was 159.09, showing the joint statistical significance of the three 
proposed instruments in predicting mental health specialist use (p<0.001). Further, Sargan-
Hansen's tests for over-identifying restrictions and Wooldridge’s score tests for exogeneity were 
performed in 2SLS-FE models even the preferred specification is 2SRI, as such tests are not 
available in a non-linear IV models. The results showed that the three instruments are jointly 
validly excluded from the second stage for each outcome. The exogeneity of mental health 
specialist use was rejected for the any ED visit/ hospitalizations outcomes (p<0.001) but not the 
number of ED visits/hospitalization days (p=0.103 for ED visits and p=0.230 for hospitalization 
days).   Accordingly, results from all instrumental variable models are presented even though 
mental health specialist care might be only endogenous to the first part of the outcome.  
4.2.2.4 Robustness check 
  Three sets of robustness checks were conducted. First, in order to examine the influence 
of unmeasured health status, the number of ED visits and number of hospitalization days from 
the prior year (lagged) were included as covariates under the assumption that prior 
hospitalization and ED visits could represent health status that are associated with mental health 
specialist care and current ED and hospitalizations (Davydow, Zivin, & Langa, 2014). Because 
of the reliance on prior year’s data for this model, including lags excluded 29.32% of the original 
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sample and reduced the estimation sample to 53,977 observations. Second, it is possible that 
treatment effects of mental health specialist care between individuals with and without severe 
mental illness are heterogeneous. Therefore, separate analyses were also conducted on the 
subgroup without severe mental illness (sample size 51,950). Finally, the estimation sample was 
restricted to individuals who were enrolled in Medicaid for at least 9 months during a year 
(sample size 64,197). Results on all those subsamples are very similar to those on the full sample. 
Therefore, they are not separately reported but available by request from the corresponding 
author. 
4.2.3 Data 
4.2.3.1 Estimation sample 
The data in this study come from the North Carolina Medicaid Analytic Extracts (MAX) 
from 2006-2011. These data files contain enrollment information and final action claims 
including outpatient care, emergency room visits, and hospitalization. The estimation sample was 
restricted to adult beneficiaries aged 18 or older with at least one inpatient or at least two 
outpatient diagnoses of diabetes and MDD during the study period (International Classification 
of Disease version 9 [ICD-9] code: 250.XX 357.2X, 362.0X, or 366.41 for diabetes and 296.2X, 
296.3X, 300.4X, or 311.XX for MDD.  Data were collapsed to annual summaries reflecting the 
total utilization in the year.  A person-year is included if the beneficiary had at least one month 
of Medicaid enrollment in that year. Person-years with Medicaid and Medicare dual coverage 
were excluded due to the potential for incomplete information on healthcare utilization. Person-
years with long-term care facility service use were excluded because those beneficiaries are less 
likely to receive outpatient visit claims. Finally, individuals were excluded if they were in one of 
the five (of 100) counties where mental health services were carved-out during this time period, 
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as mental health care utilization for such patients were incomplete in MAX files. The final 
estimation sample includes 22,392 unique persons with co-occurring diabetes and MDD during 
2006-2011, contributing 76,369 person-years to the analysis. 
4.2.3.2 Key measures 
The outcomes of interest are ED visits and hospitalization days. Both the presence and 
counts of ED visits and hospitalization days were measured.   Number of ED visits is defined as 
the total number of visits a patient made to an Emergency room for all causes during a year. This 
measure does not include ED visits that led to inpatient stays at the same facility. The average 
rate of having any ED visits is 69.5%. The average number of ED visits per year is 3.3 (Table 
4.1).  
Number of hospitalization days is defined as the total number of hospitalization days for 
all causes during a year. The average rate of having any hospitalization is 36.28% during 2006-
2011(Table 4.1). The average number of hospitalization days is 4.2 (Table 4.1). 
Mental health specialist use is the key independent variable in this study. It is defined as a 
binary indicator of whether an individual had any visits to a psychiatrist, a psychologist, a 
psychological associate, a mental health nurse practitioner, a licensed clinical social worker, a 
mental health HMO, an Assertive Community Treatment Team, or any Critical Access 
Behavioral Health Agency. On average, 31.6% of the annual observations in this study had at 
least one mental health specialist visit during a year (Table 4.1).   
4.2.3.3 Other control variables 
  Other important control variables included patient characteristics, diabetes 
complications, other psychiatric co-morbidities, and other co-morbidities. Patient characteristics 
include age, gender, and race and living in a rural area. Rural area is defined according to Rural-
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Urban Commuting Areas (RUCAs). The RUCA codes classify U.S. census tracts using measures 
of population density, urbanization, and daily commuting (United States Department of 
Agriculture Economic Research Service, 2016). As census tracts are not available in MAX data, 
RUCA codes were identified with zipcode in this study. Areas with RUCA codes lower than 4 
are defined as rural. Among the estimation sample, the average age was 45, 22% were male, 41% 
were African American, 79% lived in an urban area, and the average enrollment in a calendar 
year was 11 months (Table 4.1). 
For diabetes, nine major complications were identified and an index of diabetic 
complications was created accordingly, defined as the sum of the number of diabetes 
complications each year. Following Bethel and colleagues (2007), those diabetes complications 
included diabetic eye disease (low vision or blindness), chronic renal failure, ESRD, gangrene, 
debridement, amputation, myocardial infarction, congestive heart failure, and stroke (Bethel, 
Sloan, Belsky, & Feinglos, 2007). Any insulin use for diabetes was identified and included 
separately in the model, as insulin use typically indicates more severe diabetes associated with 
both higher outpatient and inpatient care utilization (Gamble, Simpson, Eurich, Majumdar, & 
Johnson, 2010; B. A. Young et al., 2008).  Binary indicators for bipolar disorder and 
schizophrenia were included in the model, as individuals with those conditions might be more 
likely to use both mental health specialist care, ED, and inpatient care.  
Additionally, general co-morbidities were also included in all analyses, as the 
combination of generic and diabetes-specific measures should lead to greater predictive power 
on probability of receiving different types of healthcare utilization (Maciejewski, Liu, & Fihn, 
2009). The Chronic Illness and Disability Payment System (CDPS) was applied to identify 
general co-morbidities during the year. There are twenty major categories of diagnoses in CDPS 
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(version 6.0), and most of the major categories are further divided into several subcategories 
according to the degree of the increased expenditures associated with the diagnoses (Kronick, 
Gilmer, Dreyfus, & Lee, 2000). Binary indicators for all 58 subcategories for current year were 
included in the model. 
4.2.3.4 Instrumental variables 
Three variables were identified as potential instruments: the proportion of mental health 
specialist use among Medicaid beneficiaries at the county-level, the total number of licensed 
mental health specialists in each county from North Carolina Health Professions Data System 
(HPDS) (Richman, Fraher, & Gaul, 2015), and the total number of mental health specialists 
accepting Medicaid patients generated from the MAX data. As valid instruments, those variables 
should only affect depression care outcomes through mental health specialist use and otherwise 
be independent of ED visits/hospitalizations.   The first instrument, mental health specialist use 
rate, is defined as the proportion of all Medicaid beneficiaries who had any mental health 
specialist use during the year at the county-level. The variation in local treatment selection is 
possibly through the historical practice style, which is plausibly independent of underlying health, 
preferences and outcomes of patients (Basu, Heckman, Navarro-Lozano, & Urzua, 2007). The 
full Medicaid sample regardless of diagnosis was used to generate variables reflecting total 
number of Medicaid beneficiaries enrolled by county as well as the proportion of beneficiaries 
with at least one mental health specialist visit at county-level.  
The second instrument, HPDS supply, is defined as the total number of psychiatrists and 
psychologists in a county, and comes from North Carolina Health Professions Data System 
(HPDS) (Richman et al., 2015). In theory, the supply of mental health specialists affects 
depression care through affecting mental health specialist use only. Due to data availability in 
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HPDS, this measure includes only psychiatrists and psychologists, the two major types of mental 
health specialists (Richman et al., 2015).  Nevertheless, this measure could reflect the availability 
of mental health specialist services more generally, if there is a high correlation among the 
number of psychiatrists, psychologists, and other specialists at the county level (Ellis, Konrad, 
Thomas, & Morrissey, 2009).  
The third measure, Medicaid mental health specialist supply, is defined as the number of 
mental health specialists that had seen at least one Medicaid beneficiary in a year at the county-
level. A Medicaid provider was identified from unique provider identifiers that had at least one 
claim for a Medicaid beneficiary in a year.  The unique identifiers used are state-assigned 
Medicaid billing identifiers prior to 2009 and National Provider Identifier (NPI) beginning 2009. 
The Medicaid mental health specialist supply was measured as the total number of Medicaid 
mental health specialists with at least one Medicaid-billed claim in a year at county-level. Note 
that a provider seeing patients in multiple counties could be counted more than once. The full 
sample regardless of diagnosis was used to identify Medicaid mental health specialists. All three 
instruments were merged to the analytical file by county and year. 
 
4.3 Results 
4.3.1 ED visits 
Any ED visits. Estimates of the differential effects of mental health specialist use on the 
expectation of having any ED visits are presented on the first row through Column (1) to (3) in 
Table 4.2.  The naïve probit model (Column (1)) predicts a positive association of 0.87 
percentage points (p<0.05) between mental health specialist use and having any ED visits. This 
effect became insignificant, however, in both the 2SLS model with fixed effect and 2SRI-GEE 
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model (Column (2) and (3)). The preferred 2SRI with GEE specification (Column (3)) shows 
that, with endogeneity adjusted by valid instruments, mental health specialist use is found to 
reduce 3.0 percentage point in the expected probability of having ED visits in a year, but this 
effect is not statistically significant (p=0.541).  
Number of ED visits. After adjusting for endogeneity, the GEE model (Column (4)) 
shows a significant negative effect of mental health specialist use on the number of ED visits by 
0.37 (p<0.01) in the full estimation sample. This result suggests that for an individual with co-
occurring diabetes and MDD who would increase use of mental health specialist care due to the 
changes in either local utilization pattern or higher supply of mental health specialist, receiving 
mental health specialist care will lead to 0.37 fewer ED visits during a year. 
4.3.2 Hospitalization days 
Any hospitalizations. Parameter estimation for effects of mental health specialist use on 
expectation of having any hospitalizations per year are presented through Column (1) to (3) in 
Table 4.2.  The naïve probit model (Column (1)) predicts a positive association of 4.3 percentage 
points (p<0.01) between mental health specialist use and having any hospitalizations. Both the 
2SLS model with fixed effect and 2SRI with GEE model (Column (2) and Column (3)), 
however, predict the effect in an opposite direction. The preferred 2SRI-GEE specification 
(Column (3)) shows that, with endogeneity adjusted by valid instruments, mental health 
specialist use is found to induce a significant 7.0 percentage point decrease in the expected 
probability of having any hospitalizations in a year (p<0.01). This result suggests that for a 
marginal individual who has co-occurring diabetes and MDD and would increase their use of 
mental health specialist care due to the changes in either local preference or higher supply of 
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mental health specialist, receiving mental health specialist care will significantly decrease her 
probability of having any hospitalizations.   
Number of hospitalization days. With instrumental variable methods, the GEE-IV model 
on the full sample (Column (7)) shows that mental health specialist use will induce a decrease on 
the number of hospitalization days by 0.73, but this effect is not statistically significant 
(p=0.236).  
 
4.4 Discussion  
Mental health specialist care was found to reduce the overall number of ED visits 
significantly among adult Medicaid beneficiaries with co-occurring diabetes and MDD.  The 
reduction in ED visits might have resulted from better depression management through 
outpatient care provided by mental health specialty, as MDD could worse symptoms of other 
medical chronic conditions. The preferred specification showed that mental health specialist use 
had no significant effect on the probability of having ED visits.  An exploratory analysis was 
further conducted to investigate the effect of mental health specialist care on ED visits for MDD, 
and the results showed that mental health specialist use significantly decreased the probability of 
having any ED visits with a MDD diagnosis. However, such ED visits only represented a very 
small proportion (<9%) of the all-cause ED visits in the estimation sample, implying that this 
measure might not accurately identify ED visits for MDD.  
Among those with co-occurring diabetes and MDD, individuals visited mental health 
specialists were less likely to incur hospitalizations during the same year, although mental health 
specialist care had no significant effect on the number of hospitalization days either in those with 
non-zero hospitalizations or in the full estimation population. There are plausible scenarios in 
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which an outpatient visit leads to the detection and successful treatment of a crisis that, if left 
untreated, would result in hospitalization. If mental health specialists provide better detection and 
treatment for such crisis during a patient’s outpatient visit than a primary care provider, this 
difference could lead to the reduction in probability of hospitalizations. 
The instrumental variable estimation also brings important policy implications. The 
results suggest that decrease in ED/hospitalization utilization might be achieved by increasing 
the local supply of mental health specialists. Therefore, future policies could target efforts at 
increasing such supply. An example is the Psych NP-NC program in North Carolina launched in 
2004. This program recruits and educates nurses so that they are able to provide prescriptions of 
psychotropic medications and psychotherapies when returning to their home community (Soltis-
Jarrett, 2011). The program has been successful in targeting a total of 67 counties in NC and 
graduating 74 new psychiatric nurses during 2004-2011(Soltis-Jarrett, 2011). Further studies are 
required to better understand the nature of such supply effect and to determine the effect of 
specific efforts to increase supply of mental health specialist on reducing ED/hospitalization use 
as well as improving overall population health.  
This study found that among Medicaid beneficiaries with co-occurring diabetes and 
MDD, 69.4% had at least one ED visit during a year. This is higher than what have been reported 
for those either with MDD or diabetes only, which ranged from 36.0% to 42.9% during a year 
(Himelhoch et al., 2004; Lee et al., 2008), and similar to the utilization rate as 65.0% among 
Medicare beneficiaries (Himelhoch et al., 2004).  The average number of ED visits is 3.3, 
slightly larger than the average number among individuals with diabetes and co-morbid MDD in 
another study which utilized 1996 Medical Expenditure Panel Survey (MEPS), reported as one 
ED visit in a year (Egede, Zheng, & Simpson, 2002). However, the study population was very 
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different from the present study as about one-third of their estimation sample were adults aged 
65 or more; therefore, the results might not apply to the present study population.   
This study found that 36.3% of the study population had at least one hospitalization 
during a year. This utilization rate, however, is much lower than what has been reported in a 
prior study as 66.0% among Medicare beneficiaries with diabetes and MDD (Himelhoch et al., 
2004). This could be due to the fact that the current study population experienced fewer co-
morbid chronic conditions than general Medicare beneficiaries. The average number of 
hospitalization days is 4.2, higher than the average number among those with diabetes only 
during 2010-2011, reported as 1.45 by another study utilizing Medical Expenditure Panel Survey 
(MEPS) (Zhou et al., 2015). 
Several limitations are acknowledged. First, caution should be made when interpreting 
this study’s findings, as instrument variable analysis applies to the “marginal individual.” In the 
context of this study, marginal individuals are those Medicaid beneficiaries whose increased use 
of mental health specialist care was influenced by the changes in higher supply of mental health 
specialists. The study results will not apply to individuals who change their behavior due to other 
reasons.  Second, my analysis only focuses on Medicaid enrollees, and is not generalizable to 
adults that may be uninsured or have other types of insurance. Finally, this study did not examine 
expenditures associated with ED and hospitalizations outcomes. It is possible that reduced 
healthcare use does not guarantee reduced expenditures. 
While the number of patients with multiple chronic conditions in the US has grown 
substantially from 24 % in 2001 to 28% in 2006 (Anderson, 2010), the increasing use of ED and 
inpatient care attributed to those chronic conditions has also become a leading cost driver in the 
US health care system (Schuur & Venkatesh, 2012). Findings from this study suggest that for 
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individuals with co-occurring diabetes and MDD, policies that aims to reduce ED and inpatient 
care utilization could target increasing access to mental health specialist care in this population. 
Strategies for such increased access to care can be achieved through either increasing the supply 
of licensed mental health specialists in the community or increasing participation in Medicaid 
among current mental health specialists. This study also sheds light on the potential benefits of 
mental health specialist care on reducing ED and hospitalization utilization in other complex 
population with mental health care needs. Future research exists, therefore, to carefully examine 
the impact of mental health specialist care in other populations with different combinations of 







Table 4.1 Summary Statistics on Annual Observations 
    Mental Health Specialist Use 
 
All Yes No P-
value¶  (NT=76,369) (NT=23,832) (NT=52,537) 
Outcome 
    
Any ED visits (%) 69.47 75.25 66.85 <0.001 
Number of ED visits (mean) 3.255 4.091 2.876 <0.001 
  Standard Errors (0.020) (0.043) (0.022) 
 
 
    
Any hospitalizations (%) 36.28 40.83 34.22 <0.001 
Number of hospitalization days (mean) 4.15 5.278 3.633 <0.001 
  Standard Errors (0.0053) (0.082) (0.046) 
 
 
    
Patient Characteristics 
    
Age 44.81 44.59 44.91 <0.001 
Female (%) 77.67 78.08 77.49 0.073 
Race 
   
<0.001 
  African American (%) 41.49 42.67 40.96 
 
  White (%) 51.82 52.18 51.66 
 
  Other race (%) 6.91 5.42 7.59 
 
Rural (%) 21.42 21.11 22.99 <0.001 
Number of months of Medicaid Enrollment (1-12) 10.68 11.38 10.36 <0.001 
 
    
Clinical Characteristics 
    
Total number of diabetes complication (0-9) 0.52 0.53 0.52 0.005 
Total number of diabetes complication, exclude 
diabetic eye disease (0-8) 
0.29 0.27 0.30 <0.001 
  Diabetic eye disease (%) 23.60 26.61 22.23 <0.001 
  Gangrene (%) 2.47 2.66 2.38 0.022 
  Debridement (%) 2.22 2.19 2.24 0.650 
  Amputation (%) 0.78 0.72 0.81 0.186 
  Chronic renal failure (%) 6.06 6.22 5.99 0.228 
  End Stage Renal Disease, ESRD (%) 0.90 0.71 0.99 <0.001 







    Mental Health Specialist Use 
 
All Yes No P-
value¶  (NT=76,369) (NT=23,832) (NT=52,537) 
  Congestive heart failure (%) 9.13 7.99 9.65 <0.001 
  Stroke (%) 3.18 2.68 3.41 <0.001 
Any insulin use (%) 30.38 32.08 29.60 <0.001 
 
    
Severe mental illness (%) 20.19 40.20 11.11 <0.001 
¶ Chi-square tests were performed for categorical variables and T-tests were performed for continuous variables. Severe mental illness includes schizophrenia 






Table 4.2 Differential Effect of Mental Health Specialist Care on ED Visits and Hospitalization Day 
 
  













      
 


















     








Number of unique individuals (N) 22,392  22,392  22,392    22,392  
 
     
Hospitalization days 0.043 ** -0.05 
 
-0.070 ** -0.73 
 

















         
 
   








Number of unique individuals (N) 22,392  22,392  22,392    22,392  
2SLS-FE: Two stage least square with person-level fixed effect. 2SRI: Two stage residual inclusion with raw residuals. GEE: General Estimating Equations. In 
all models, other control variables not reported include year dummy variables (2006-2011) and CDPS indicators (58 dummy variables). Standard errors are 
estimated with delta-method for differential effect estimation in Probit and 2SLS-FE. Standard errors are estimated with bootstrapping methods with 1000 
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CHAPTER 5. DISCUSSION 
The objective of this study was to examine the effect of the mental health specialist care 
on healthcare utilization of adult Medicaid beneficiaries with co-occurring diabetes and major 
depressive disorder (MDD) in North Carolina. This study examined the effect of mental health 
specialist care on guideline-concordant diabetes care (Chapter 2), guideline-concordant 
depression care (Chapter 3) and, the emergency department (ED) and hospitalization care 
utilization (Chapter 4). North Carolina Medicaid claims data (MAX) were used to analyze 
outcomes of healthcare utilization with appropriate specifications, including person-level fixed 
effect (Chapter 2-4), Instrumental variable method (Chapter 2-4), and Generalized Estimating 
Equations (Chapter 4). In this final chapter, the study findings are summarized and their 
implications for policy, limitations, and future research on mental health specialist care are 
discussed. 
 
5.1 Summary of Study Findings 
The main findings of this dissertation could be summarized as the following. First, 
mental health specialist care affects guideline-concordant diabetes care in two different 
directions among individuals who would change their treatment choices due to changes in local 
supply of mental health specialists. It improves adherence level of annual eye exam and 
likelihood of having visited a primary care provider, but it decreases adherence level of annual 
lipid test and two A1c tests during a year, two important primary care-based preventive check-
ups. Second, mental health specialist care leads to higher adherence level to guideline-
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concordant depression care, measured as at least 84 days covered antidepressant prescription or 
four psychotherapy visits during the acute phase of a depression treatment episode. Finally, 
mental health specialist care reduces the overall number of all-cause ED visits and the 
probability of having any all-cause hospitalizations. Therefore, among adults with co-occurring 
diabetes and MDD, mental health specialist care improves quality of depression care, but might 
reduce quality of diabetes care at primary care. Further, it also reduces tertiary care utilization 
through decreasing both the overall number of ED visits and the likelihood of hospitalizations. 
 
5.2 Implications  
The availability of providers to care for patients is the foundation for all health care 
delivery. Unfortunately, many areas in the US continue to have shortages of health care 
professionals, especially for mental health care. As mental health specialty supply is predicted to 
remain low, how to efficiently allocate mental health workforce among those with mental health 
care needs has became a critical policy issue. The high level of unmet need as well as the high 
cost among individuals with co-occurring mental health and physical conditions suggest that this 
population deserves increased attention. It is important to examine the role of mental health 
specialists in caring for this population as well as how mental health specialist care affects other 
types of healthcare utilization.  
This dissertation study addresses the most critical aspect of the mental health specialist 
care issues among a specific complex patient population and brings important policy 
implications. Overall, despite the fact that primary care providers have been more engaged in 
providing depression care, mental health specialist care is found to generally improve healthcare 
utilization outcomes among adults with co-occurring diabetes and MDD.  Specifically, mental 
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health specialist care could improve quality of depression care and reduce ED and inpatient care 
utilization. This implies the possibility that the clinical significance of mental health specialist 
care could still outweigh the potential high marginal cost of visiting a mental health specialist in 
this specific population.  Policies aiming to improve healthcare utilization outcomes in this 
population could target at improving access to mental health specialist care through increasing 
licensure workforce or Medicaid participation among mental health specialists. 
The negative effect of mental health specialist care on some primary care-based quality 
indicators for diabetes care, however, implies that any policy aiming to improve mental health 
care delivery also needs to address the spillover effect of mental health care on other co-
occurring physical conditions.  Study results suggest that due to potentially limited available 
resources or competing demand during a primary care visit, healthcare demand for one chronic 
condition might crowd out demand for another condition. As individuals with multiple chronic 
conditions tend to present greater challenges to achieving quality goals designing for those with a 
single condition (Werner, Greenfield, Fung, & Turner, 2007), future policies should focus on 
developing a comprehensive care model that addresses specific quality performance in this 
population. 
 
5.3 Limitations  
Specific limitations for have been addressed in each of the previous chapter. Overall, this 
dissertation is subject to several potential limitations. First, Medicaid claims data does not have 
information on the severity of symptoms (mental health or physical health), and the ability to 
describe a beneficiary’s clinical severity based on claims data is restricted (Iezzoni, 1990). 
Although this study controlled comorbidities in different forms, it id not provide answers to 
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questions specific to severity of symptoms. For example, this study cannot examine weight 
change or MDD severity after a patient sees a specialist. However, with understanding of the 
effect of mental health specialist care on overall health built from this study, future research with 
primary data collection or Medical record abstractions to collect severity of symptoms or clinical 
outcomes could help researches to further study the effect of mental health specialist care on 
disease-specific severity among this population. 
Second, the provider licensure data is available for limited number of categories of 
mental health specialist. Although HPDS is an excellent dataset with richer NC workforce 
information than other available data sources, it is still lacking information of some types of 
mental health specialists.  For example, information of counselors, social workers, and family 
and marriage therapists are not available as of this writing. However, psychologists and 
psychiatrists are two most important types of shortage among all mental health providers and 
deserve major attention. This study will still answer important policy questions even without 
weighting in supply information of some other types of provider.  
Third, the county-level supply of Medicaid provider is measured as the number of 
Medicaid mental health specialist in a year at county-level. However, this measure is subject to 
potential bias.  A provider could be counted more than once as she might be identified from 
different counties in a year and could lead to overestimated numbers of providers. Further, the 
unique id used was state-assigned Medicaid billing identifiers prior to 2009 and National 
Provider Identifier (NPI) beginning 2009. Medicaid billing identifiers are more likely to be 
practices, while NPI are more likely to be clinicians. Therefore even when the actual supply 
stays stable over years, it may still show an increasing trend during the study period with those 




5.4 Next Steps 
As this dissertation was focused on adult Medicaid beneficiaries in North Carolina, 
implications yielded from the study results might only apply to this specific population. For 
example, study findings might not be generalizable to Medicare beneficiaries, as the elderly 
population with multiple chronic conditions might occur higher ED and hospitalization 
utilization than their younger counterparts. Further, individuals with different combinations of 
physical and mental health conditions might have different treatment choices for mental health 
care than those with co-occurring diabetes and MDD. Future areas of research, therefore, exist to 
carefully examine choices for mental health care as well as to determine the effect of mental 
health specialist care on other populations with different insurance types, different demographics, 
or different combinations of chronic conditions. 
In the spirit of promoting integration between behavioral healthcare and medical care, a 
natural extension to the current study would be to evaluate whether patients with mental health 
and physical health chronic conditions benefits more from mental health specialist care in a 
coordinated, comprehensive, and patient-centered care setting. Those models that adapted the 
patient-centered multidisciplinary approach include medical home models, community health 
teams, and primary care and behavioral health integration models (US Department of Health and 
Human Services, 2010).  Research interests have emerged with regard to the impacts of such 
models on quality of care among individuals with co-occurring mental and physical chronic 
conditions. For example, a recent study has found that medical home enrollment is generally 
associated with greater likelihood of receiving guideline-concordant diabetes care for Medicaid 
enrollees with diabetes and schizophrenia (Olesiuk et al., 2016). Future research should carefully 
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evaluate the role of mental health specialists in those models, as well as impacts of those models 
on mental health specialist use and other healthcare utilization of individuals with mental health 
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APPENDIX: SELECTED AVERAGE MARGINAL EFFECT ESTIMATIONS ON ED 
VISITS AND HOSPITALIZATION DAYS 
 
Appendix Table 1 Selected Average Marginal Effect Estimations on ED visits 
  (1) (2) 
 




























Race (Reference: Caucasian) 
  
















































          
Sample Size (N) 76,369  
76,369 
 
Number of unique individuals (N) 22,392   22,392   
2SRI-raw: Two stage residual inclusion with raw residuals. GEE: General Estimating Equations. IV: Instrumental 
variable method. In all models, other control variables not reported include year dummy variables (2006-2011) and 
CDPS indicators (58 dummy variables). Standard errors are estimated with bootstrapping methods with 1000 




Appendix Table 2 Selected Average Marginal Effect Estimations on Hospitalization days 
 
































Race (Reference: White) 
  
















































         
Sample Size (NT) 76,369  
76,369 
 
Number of unique individuals (N) 22,392   22,392   
2SRI-raw: Two stage residual inclusion with raw residuals. GEE: General Estimating Equations. IV: Instrumental 
variable method. In all models, other control variables not reported include year dummy variables (2006-2011) and 
CDPS indicators (58 dummy variables). Standard errors are estimated with bootstrapping methods with 1000 
iterations for 2SRI and GEE-IV. *p<=0.05 **p<0.01  
 
